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A 
to the 
by jean Murray 
The Fairview-University partnership 
is designed to sustain and 
enhance research and education. 
2 
• 
fl 
airview and U niversity hospitals have been across-
the-river neighbors for years, but now they have 
bridged that distance to become partners. On 
January 7, U niversity and Fairview officials signed 
the Academic Affiliation Agreement and the Asset 
Transfer and Statuatory Merger Agreement, making 
the merged entity official. 
The new Fairview-University Medical Center "creates a rela-
tionship designed to preserve the education and research mission of 
the University," says Dr. Frank Cerra, provost of the University's 
Academic Health Center (AHC ). "Fairview has shown a unique 
willingness to become a partner in the U niversity's education and 
research programs." 
The partnership has been more than a year in the making, but 
the evidence that such a union would eventually be necessary has 
been growing for a decade. 
Preserving education and research 
Since 1911, the University of Minnesota Hospital has been a place 
where medical students could learn how to work with real patients 
and researchers could expand their knowledge of the causes and 
treatments of disease. Income from patient care helped support 
research and teaching programs. 
But in the 1980s, change began to take place throughout the 
country. Hospitals began experiencing decreasing numbers of 
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patients, due to health-care reform - which 
placed limits on hospital stays - and advancing 
technology and procedures that pennitted people 
to be treated in clinics rather than hospitals. Some 
hospitals closed, and others merged into networks 
with other hospitals or health maintenance organi-
zations. 
The situation was especially acute at the 
University of Minnesota Hospital and C linic 
(UMHC ), located in one of the nation's most com-
petitive managed care markets. Admissions 
declined 14 percent in the last five years, with 
UMHC holding only 5 percent of the market. 
"We did not have enough patients to 
teach our students, conduct research, 
maintain our accreditation, and under-
write the cost of health care education," 
explains Cerra. 
Creating Fairview-University 
Medical Center: the University of 
Minnesota Hospital (top), and 
Declines in patient census and in-
come jeopardized the Academic Health Center's 
research and education mission. Despite substantial 
cutbacks of staff, the hospital continued to lose 
money, with losses projected to be $100 million to 
$150 million by 2000 unless changes were made. 
A mutually beneficial solution 
The University concluded that in order to have a 
large enough number of patients to treat, and to 
restore financial stability, it would need to join 
forces with a successful health care system. Just as 
important, it was essential that the new partner sup-
port the University's academic and research missions. 
On November 16, 1995, the University signed 
a letter of intent to discuss a partnership with the 
Fairview Health System, believing that Fairview's 
strong community-based care would complement 
the University's advanced specialty care. The 
University's Board of Regents approved the trans-
action on July 29, 1996, and on January 1, 1997, 
UMHC employees became Fairview employees. 
According to Cerra, "The UMHC -Fairview 
agreement represents the first time a health system 
has offered to help an academic health center pre-
serve its education and research mission. Finding a 
partner committed to that mission, as well as to 
quality patient care, was essential to the entire 
AHC's future. Under the agreement, the new com-
bined hospital will continue to be a world-class 
University hospital." 
Dr. Gordon Alexander, senior vice president 
and medical director for Fairview Health System, 
says, "With this affiliation, we are expanding a 
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Fairview Riverside Hospital. 
commitment to all citi-
zens of Minnesota. We 
will form a las ting part-
nership with the Uni-
versity to maintain and 
extend the highest qual-
ity patient care, medical 
education, and research." 
Fairview has agreed 
to change its mission 
statement to allow it to 
more deeply support 
research and education. 
The new mission state-
ment reads: 
"The mission of the 
Fairvi ew-Uni ve rs ity 
Medical Center is to im-
prove the health of Min-
nesota communities by providing excellence in 
health services, education, and research, while 
meeting the physical, mental, and emotional needs 
of individuals and families served, and honoring the 
spiritual dimension of health." 
University President N ils Hasselmo says, "We 
are creating a new model for the nation for an aca-
demic health center in the new managed care 
scene. It is truly a historic moment and an idea 
whose time has come." 
How does it work? 
The agreement brings the University of Minnesota 
Hospital and C linic into the Fairview Health 
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We will form a lasting partnership with the University to maintain and 
extend the highest quality patient care, medical education, and research. 
System, a network of seven hospitals and 2 7 clinics 
serving the Twin C ities metropolitan area. The 
Fairview-University Medical Center, which com-
bines the University and Fairview Riverside hospi-
tals, is one division of the Fairview system. 
The University will receive $87.5 million from 
Fairview for purchase of the University of Min-
nesota Hospital and Clinic. After retiring long-
term debt and paying transaction costs and other 
liabilities, the University will have an estimated $70 
million to be used for continued AHC restructuring, 
restoration of central services, technology, equip-
ment, and administrative systems investments. 
The University will cover $1 million per 
month in research and education costs at Fairview-
University Medical Center during a 32-month 
transition period. Estimated research and education 
costs for the division's first year are $15 million to 
$38 million. 
Each year, Fairview will contribute 25 percent 
of its operating margin in excess of 3.5 percent to 
the University for medical research and education. 
Fairview and the University will share the ongoing 
costs of medical research and education. 
The relationship between the University and 
Fairview is preferred but not exclusive, with the 
Academic Health Center maintaining the option 
of developing and placing education and research 
programs, including clinical services, at other sites. 
The University retains full authority for educa-
tional and research policies, curriculum design, desig-
nation of education program leadership, academic ap-
pointments, and all related academic policy matters. 
Logistics and governance 
The new Fairview-University Medical Center is 
divided by the Mississippi River, and the integra-
tion of medical and surgical departments is a com-
plicated task. Fairview and University administra-
tors have been working on an operating model that 
consolidates the two campuses and eliminates as 
much duplication as possible. The complete transi-
tion is expected to take about 32 months. 
The majority of inpatient medical and surgical 
care will be on the University side of the river, and 
subacute care and rehabilitation on the Fairview side. 
The current plan for specialties at the two sites includes: 
University campus: Critical care; pediatrics; 
emergency room; medical and surgical oncology; 
bone marrow transplant; heart catheterization; 
ophthalmology; all inpatient surgery except benign 
orthopaedics (including spine) and benign gynecol-
ogy; inpatient ear, nose, and throat; and outpatient 
surgery at physician's choice, consistent with 
scheduling capability. 
Fairview campus: Acute rehabilitation; behav-
ioral health and chemical dependency; obstetrics 
and newborn intensive care unit; urgent care/emer-
gency; benign orthopaedics (including spine) and 
benign gynecology; critical care/recovery center 
capability; and outpatient surgery at physician's 
choice, consistent with scheduling capability. 
University employees were not required to 
start over in the Fairview organization as new 
employees. The state legislature provided $1.8 mil-
lion, matched by the University, to ease the transi-
tion of UMHC employees. 
he Fairview-University Medical 
Center will be governed by a 
Board of Trustees, accountable to 
the Fairview System's Board of 
Directors. A majority of the divi-
sion trustees will be appointed by 
the University. University appointees will also 
hold about a third of the seats on the Fairview 
System's overall board. 
The University's Board of Regents elected 
seven members to the Fairview-University Medical 
Center's Board of Trustees. They include: Roby 
Thompson, M.D., chief medical officer for the 
University of Minnesota Health System; Edith 
Leyasmeyer, Ph.D., M.P.H., dean of the University's 
School of Public Health; and John Morrison, chair 
and owner of Central Bank Group, elected to three-
year terms; Jonathan Ravdin, M.D., chair of the 
University's Department of Medicine; and Thomas 
Madison, MLM Partners president and CEO, elect-
ed to two-year terms; Michael Dougherty, founder, 
president and CEO of Dougherty Dawkins, Inc., and 
Nellie Johnson, CEO of Optage/Care Partners, 
elected to one-year terms. 
The University's Vice President for Finance, 
the Academic Health Center provost, and the 
dean of the Medical School will be permanent, ex-
officio, voting members of the System Board. 
Enhanced education and 
research opportunities 
Academic Health Center appointments - includ-
ing chairs and department heads - will continue 
to be completely controlled by the AHC in accord 
with its policies and procedures, and academic 
affairs will be governed by AHC policies and pro-
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Why is the University/AHC 
entering into this rerationship? 
cedures. Current Medical School pro-
grams and student, resident, and fellow 
commitments will be maintained. 
• To increase access to patients in order to mainta in and enhance the 
AHC mission and the clinica l competency of its faculty. 
"Hopefully, the Fairview System will 
be asked for input in the AHC mission," 
says Fairview's A lexander. 'We would not 
be asked to drive it. 
• To enable the AHC to be competitive in the healthcare marketplace. 
• To enhance the eff iciency and effectiveness of cl inical services 
provided in the academic setting. 
• To preserve and grow an on-sit e, world-class hospital and cl inic 
system for the AHC. 
"More and more acute care is pass-
ing out of the hospital and into a broad-
er system," says Alexander. "This affi lia-
tion gives the University more access to 
that system, more chances that leading-
edge research can be done." 
• To provide new opportunit ies for education, research, and service/ 
outreach development. 
• To stabilize a portion of the AHC f inancial base by ensuring greater 
community support for t he AHC mission. 
The Research and Education 
Committee of the Fairview System 
Board will be chaired by the AHC 
• To enable the health professions to achieve re levance, leadersh ip, 
and excellence into t he 21st century. 
provost. Duties of the committee will include: 1) 
Developing the education and research program of 
the System, including that associated with 
Fairview-University; 2) Developing research policy 
and procedure of the System; 3) Mon itoring 
research and education programs; and 4) Perform-
ing periodic assessments of the education and 
research programs. 
The AHC and Fairview have agreed to maxi-
mize collaboration for research. The University is 
the sponsor for all basic research, and an academic 
appointment is required to be the principal inves-
tigator or to conduct basic research. Either the 
University or Fairview may sponsor cl inica l 
research and outcomes/health systems research, 
and the principal investigator may be from either 
the University or Fairview. 
Fairview and the Academic Health Center 
have made mutual commitments to: 
1. Support and encourage health-related educa-
tion, research, and patient care at Fairview-
University and throughout the Fairview System. 
2. Support and encourage efforts to allow 
Fairview-University, the System, and University of 
Minnesota C linical Associates, and Fairview affili -
ated physicians to compete effectively in the mar-
ketplace. 
3. Position Fairview-University as a world-class, 
regional referral center. 
4. Develop cost-effective care models that 
respond to the marketplace. 
5. Provide a quality-enhancing and cooperative 
environment that permits the interaction of com-
munity-based and academic-based health care 
providers. 
6. Exercise prudent stewardsh ip of resources so 
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that Fairview-University is an effective, cutting-
edge provider within the Fairview System and the 
AHC continues to be a highly reputable health-
related teaching and research institution. 
7. Support health-related research, education, 
and clinical care at the AHC. 
8. Commit to continuous quality improvement. 
9. Regularly consult and communicate with each 
other. 
Benefits 
Those who have been involved in bringing togeth-
er the University Hospital-Fairview Riverside part-
nership are optimistic about the future. 
For Minnesota, they believe the partnersh ip 
means that the state's premier research and educa-
tion programs can thrive in an environment that 
preserves academic integrity while offering cost-
competitive services. 
For patients, they envision access to a fu lly 
integrated, statewide health-care system with coor-
dinated services ranging from illness and injury pre-
vention to treatment of the most unusual and com-
plex cases. 
For students, the partnership means access to 
the broad patient base that is needed for learning 
and conducting clinical studies. They will also be 
part of an enhanced educational experience within 
a health system that will offer a preview of what 
they will likely find in practice. • 
For more information on the Fairview-
University Medical Center, visit the website 
at: http://www.ahc.umn.edu/ufa.html. 
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Electrodes placed 
in Bob Zgonc's 
brain stimulate 
the pallidum. 
6 
S ti1nulation: 
Innovative relief for Parkinson's disease 
ot too long ago Anton "Bob" Zgonc's (pronounced sconce) 
body moved so uncontrollably and continuously that it 
was like an 18 hour aerobic workout. At other times, he 
suffered from extreme cramping that left him virtually 
immobile. He only had about one good hour every day. Otherwise he spent his 
days in pain, sitting in a recliner at home. 
The medication Zgonc had been taking to manage his Parkinson's disease 
for the past 11 years was no longer working. Zgonc and his wife, Sharon, began 
to search for options. 
At the University of Minnesota, the Zgoncs found new hope. Researchers 
and surgeons at the University have 
University surgeons implant new electrical device been forging new ground in Parkin-
to relieve Parkinson's disease patients' symptoms. 
By Jodi Ohlsen Read 
son's disease treatment. To understand 
these treatments, it is first essential to 
understand what happens in the brain 
of a Parkinson's disease patient. As 
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Research: 
pursuing a cure 
U niversity of M innesota investigators are involved in a number of other research programs on Parkinson's 
disease. For example, researchers are studying 
cell transplantation and gene therapy as a way 
to manage the disease. 
"In gene therapy, there are growth factors that 
could influence the rate of degeneration of the 
dopamine-producing cells and actually prevent 
them from dying out," says Walter Low, Ph.D. 
"Currently we' re looking at taking specific genes 
and inserting them into a cell so that they begin 
to secrete neurotropic growth factor. What we'd 
ultimately like to do is encapsulate those cells 
into a polymer so that these cells can continue to 
secrete the growth factor. We'd then implant 
them into the area of the dopamine-producing 
cells and see if we can prevent the progressive 
deterioration of these particular cells." 
Dr. Walter Low, professor, Department 
of Neurosurgery, explains, "Certain 
areas of the brain are involved in regu-
lation of movement. In Parkinson's 
disease, the basal ganglia is the struc-
ture that seems to undergo degenera-
tion. The key area within the basal 
ganglia is the cluster of cells called the 
substantia nigra. These cells produce 
the chemical dopamine, which plays a 
According to Low, researchers have already found that transplanted 
dopamine cells can grow, form new connections, and actually prevent the 
kind of motor deficits seen in Parkinson's. "It is complimentary to the stim-
ulation approach," explains Low. "Stimulation has an immed iate impact 
but isn't reparative. What we are trying to do with cell transplantation is 
restore the connections that have been lost as a result of the degenera-
tion." At this point, Low is preparing to begin a pilot clinical trial of cell 
transplantation . 
crucial role in transmitting signals from the brain 
to the muscles. 
"With Parkinson's disease there is a progres-
sive degeneration of those dopamine-producing 
cells. As a result, there is a loss of cells and nerve 
fibers that reach out and talk to other cells in 
parts of the brain. It has been found that the 
absence of dopamine causes an increase of abnor-
mal activity in a couple of areas, the internal pal-
lidum and the thalamus." Patients with Parkin-
son's disease suffer from symptoms which include 
disabling tremors, rigidity, slowness of movement, 
uncontrolled movements (dyskinesia), and mus-
cle cramping. 
To help control the symptoms of Parkinson's 
disease, chemicals that are precursors to dopa-
mine, such as L-dopa, can be used. However, as 
Zgonc experienced, the drugs become less and less 
effective, even causing side effects. "The drugs 
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weren't working anymore," says Sharon Zgonc. 
"Cramping is a side effect of the drug and Bob 
had such extreme cramping - three to four 
hours at a time. It was very painful and left him 
immobile. He has been taking the drug for 11 
years and as time went by he had to take more 
drugs but with more drugs you get more side 
effects. Without the drugs he was worse. What 
could we do? It was a catch-22." 
In January 1996, University surgeons per-
formed a successful pallidotomy on Zgonc to con-
trol the symptoms on his left side. "They drill a 
hole in your head, right here," says Zgonc, point-
ing to a spot near the front of his head. "Then 
they go in a make a little 'cut', a lesion." 
"And that prevents the abnormal signals 
from getting through," continues Sharon Zgonc. 
"The pallidum is the size of an appleseed and by 
severing the connections, the signals can't get 
7 
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Bob and Sharon Zgonc, 
above. Above right, the 
deep brain stimulator, made 
by Medtronic. 
through and all of his symp-
toms, everything, went 
away. The pallidotomy was 
on the right side of his brain 
and the left side was affect-
ed. But, we still had to deal 
with the Parkinson's on his 
right side." 
A second pallidoto-
my was not recommended 
since it could cause possible 
language problems. Instead, 
the Zgoncs chose to try 
the ir luck with a new 
method used on only a 
handful of patients worldwide- deep brain stim-
ulation. "This is a modification of the pallidoto-
my," says Low. "Rather than making a hole - or 
lesion - we're actually placing electrodes into 
the pallidum. These electrodes are in tum con-
nected to a battery which stimulates the pallidum 
at a frequency that suppresses nerve cells in the 
region. As a consequence, we can then normalize 
the neural activity in these other areas of the 
brain." 
With the deep brain stimulation device, the 
treatment can be modified to fit each patient's 
needs. "The electrodes are much smaller than a 
lesion. There are four tiny electrodes that allow 
us to selectively activate each one to find out 
which area is the best to stimulate. It is a much 
more refined way of inhibiting nerve cell activity 
in the area of the pallidum," says Low. 'There are 
other features, too. In addition to being able to 
select the area for stimulation, the device is pro-
grammable so we can adjust the electrical stimu-
Ius intensity, increase its duration, or increase its 
frequency of stimulation. We can tailor it to the 
individual patient." In addition, no tissue is 
destroyed so the electrode can be reimplanted 
without damaging the brain, if needed. 
The deep brain stimulator, made by Med-
tronic, is somewhat similar to a pacemaker. High 
frequency electrical stimulation is used through an 
electrode placed in the brain rather than the heart. 
uring surgery the patient is 
sedated but awake. This 
allows the patient to give 
feedback during the opera-
tion, which is necessary to 
properly place the device. To 
map out the area of the pallidum, surgeons place 
electrodes in the brain to record activity in the 
pallidum. They can then map precisely where 
the electrode should be located. A thin wire 
probe is inserted into the pallidum intemus of 
the brain and a sophisticated battery that gener-
ates electrical pulses is placed under the skin of 
the patient's chest. The electrical signals can be 
turned on and off with a small but powerful mag-
net held near the battery. 
On October 2, 1996, Bob Zgonc underwent 
successful surgery to implant the deep brain stim-
ulator. Now only a small raised bump is barely 
noticeable on the top of his head, close to the 
front of his hairline. He turns the device on with 
the small battery and turns it off at night to 
extend the battery life. When it does wear out, it 
will be replaced through a small incision in the 
skin, similar to the battery replacement for a 
pacemaker. Zgonc also carries a small, portable 
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radio that he uses to reassure himself 
that the device is on. If he holds the 
radio close to himself, he can hear 
the interference caused on the AM 
channel of the radio, signaling that 
the device is working. 
The dramatic changes in Zgonc 
are more than enough to show that 
the device is working. During a rou-
tine checkup, Zgonc was asked to 
perform some simple exercises to 
evaluate the effectiveness of the 
deep brain stimulator. Without any 
medication and. with the device 
turned off, Zgonc will get up from a 
chair and walk a short distance. The 
pain is already evident as he sits, 
tremors beginning in his right hand 
and cramping distorting his face 
Above, Zgonc's surgeon, Dr. Robert Maxwell and Sharon Eriksen, 
R.N., C.N.R.N., members of the Parkinson's research team. 
and leg. Sharon Zgonc brings him warm, wet 
towels to help soothe the pain in his face and 
neck. With great effort, he rises and begins the 14 
meter walk. At one point, he is unable to move 
forward. Sharon Eriksen, R.N., C.N.R.N., puts 
her foot in front of his to prompt the walking 
reflex and he is able to return to his chair. 
Exhausted, he puts his head in his hands. 
ext, with the stimulator on, 
Zgonc is sitting in the chair, 
waiting to begin. His entire 
countenance is strikingly dif-
ferent - his face is relaxed, 
his legs resting comfortably. 
On cue, he rises easily from his chair and quickly 
walks to the mark and back. With confidence, he 
sits back down in the chair. It only took him a 
fraction of the time to complete the exercise. 
The impact on Zgonc's daily life is even 
more dramatic. Where he was once lucky to have 
one hour a day of normal living, he now fully 
enjoys daily activities like doing things around 
the house, even driving. Recently he even took 
his grandchildren sledding. He's been able to 
resume hunting, once a favorite pastime. This sea-
son he went on a 14-day hunting trip and actually 
ran through the woods in successful pursuit of a 
deer. "He has his independence back," says Sharon 
Zgonc. "It's a 100 percent improvement." 
Her life has also been deeply affected by 
Zgonc's increased independence. Previously she 
spent nearly all of her time caring for Zgonc since 
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Activities of Daily Living* 
OnMed OnMed 
On Stim 
Shopping in the mall 
carrying luggage 
Driving a car 
Spending time alone 
Hunting deer 
Sleeping all night 
Maintaining weight 
Spouse able to go back to work 
* Activities Bob Zgonc has been able to resume. 
he was in such pain and was unable to do many 
things for himself. But Sharon Zgonc does not 
focus on her own sacrifices. "Some handle it and 
some don't. It's just how you do things. 
Remember, we could keep going but he's the one 
who had to sit back and not participate." Now 
she is able to "have a little breather" and has 
even resumed working part-time. 
Zgonc continues to take medication along 
with using the stimulator. "The medication and 
the device seem to work together," says Low. 
"Zgonc, for example, still takes medication and it 
helps a little. Then he turns on the stimulator to 
improve his ability to move. You can think of it 
as a bumpy course of events with medication. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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SUPER: SuP-~orters United for 
Parkinson s Education and Research Low. Initially, Low hopes to enrolllO 
patients and after preliminary data 
has been gathered, the study will 
expand. "Hopefully, we'll be able to 
demonstrate that this is an excellent 
therapy for the subset of patients that 
no longer respond to medication," he 
says. 
S UPER (Supporters United for Parkinson's disease Education and Research) was formed in 1992 by a number of people who have Parkinson's disease and their families and friends. Its mission is to inform the public about current research developments and to raise 
funds for Parkinson's disease research at the University of Minnesota. 
SUPER is also a fund of the Minnesota Medical Foundation, which raises and 
manages private funds on behalf of t he University of Minnesota Medical 
Schools. Gifts to SUPER support Parkinson's disease research in the 
Department of Neurosurgery. 
"Mr. Zgonc is very courageous to 
participate in this," says Low. "He is a 
real pioneer. He realizes that the 
results here may one day open the 
doors for its use on a general basis, for 
many patients with. Parkinson's dis-
For more information about SUPER, contact Noelann Brown, Minnesota 
Medication Foundation, Box 193, 420 Delaware Street SE, Minneapolis, 
Minnesota, 55455-0392, 1-800-922-1MMF or 612-625-1440. 
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What the stimulator does is smooth out the 
bumps so he doesn't go into states with dyskinesia 
and discomfort." 
Zgonc is one participant in a study Low and 
Dr. Robert Maxwell are heading to look at 
Parkinson's disease patients whose medication is 
no longer effective. Other members of the 
research team include Sharon Eriksen, Drs. 
Ttmothy Ebner and Michael Johnson in the 
Department of Neurosurgery, Dr. John Anderson 
in the Department of Otolaryngology, Dr. Deb-
orah Roman in Physical Medicine and Rehabili-
tation, Dr. Nancy Solomon in the Department of 
Communication Disorders, Dr. Charles Truwit in 
Radiology, Dr. Paul Tuite in Neurology, and Drs. 
Paul Silverstein and Felix Zwiebel of the 
Struther's Parkinson's Center. 
n the current clinical trial, the researchers 
are examining patients of a particular 
age range and certain disability level. A 
good candidate for the deep brain stim· 
ulator would be a patient who no longer 
responds to the medication, is fairly dis-
abled, and is not suffering from severe dementia 
or other disorders similar to Parkinson's disease. 
Patients participating in the clinical trial will 
be evaluated periodically over three years. "We 
have a core evaluation that looks at how quickly 
they can stand and walk a certain distance; how 
well they move their limbs and fingers; and neu-
rological assessments of balance and speech," says 
To find out more about the University of Minnesota's 
Department of Neurosurgery, please visit the neuro-
surgery website at http://www.neuro.umn.edu. 
ease." Zgonc is the first person in 
Minnesota and only the third or fourth in the 
country to have deep brain stimulation of the 
pallidum, yet both he and Sharon Zgonc are some· 
what nonchalant about the magnitude of their con-
tribution. 
"I had to do something," says Zgonc. Sharon 
Zgonc adds, "He was an excellent candidate. He's 
in excellent health, except he has Parkinson's. 
What were we going to do? He couldn't go on the 
way he was. So we decided why not take a 
chance? We knew it wasn't a cure. We said if he 
could just walk, that would make us happy. 
We've accomplished that, and then some. Maybe 
what we are doing can show that it is worth it, and 
then the next people down the line can benefit." 
Since the procedure is still considered exper· 
imental, the Zgonc's insurance company refused 
to cover the expenses. In a rally of support, resi-
dents of Zgonc's home town, Chisholm, Min· 
nesota, and surrounding communities began rais-
ing money for Zgonc's surgery. A large portion 
was raised at a town pasta feed and benefit. "I 
think everybody in Chisholm ate rigatoni that 
night," says Sharon Zgonc. "And Hibbing, and 
Virginia, and even as far away as Duluth and 
Bemidji." Church organizations and other groups 
contributed and many sent money anonymously. 
So far the Zgoncs have received 18 to 20 thou-
sand dollars. 
Zgonc is well liked and respected in Chis· 
holm. He worked as a state trooper for many 
years. "Obviously the kindness and caring he 
gave to others turned around and came back to 
him. Twentyfold," says Sharon Zgonc. Now 
Zgonc is again active in his community, visiting 
those who are ill and most importantly to him, 
giving back to his supportive community. • 
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Biotherapy Institute Fights 
the Toughest Diseases 
by Jean Murray 
SPRING 1997 
nnovative research and treatment is providing hope where 
often none existed at the new Biotherapy Institute at the 
University of Minnesota. The goal of the Institute, found-
ed in 1996, is to develop research discoveries with the 
potential to improve treatment of cancer, AIDS, and dis-
eases of the immune system. 
According to Institute Director Fatih Uckun, M.D., 
Ph.D., "Biotherapy selectively seeks out and destroys can-
cer cells without disturbing nearby healthy tissues. We are working toward 
designing effective therapies for cancer patients unable to benefit from 
standard chemotherapy." 
Biotherapy research has been underway at the University since 1984, 
but the work was expanding rapidly, creating a need for larger facilities. In 
June, 1996, the Biotherapy Institute moved into new, state-of-the-art 
facilities in Roseville. 
"The Institute is growing at such a rapid pace that it was necessary 
to triple the size of our facilities to accommodate our staff and their 
research," says Uckun. "This is a new home for scientists from all over the 
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Dr. Fatih Uckun, director of the Biotherapy 
Institute, right. Above, molecular biologist 
Dr. Sandeep Mahajan. 
world to work together for a common goal. The 
fac ility has everything necessary to enable this 
team to develop and test new targeted therapies 
applicable to a wide array of diseases." 
The research space is divided into cell biolo-
gy, molecular biology, signal transduction, bio-
chemistry, and synthetic chemistry laboratories. 
Biotherapy Institute faculty also occupy space in 
U k d h. t h the Minnesota Molecular c un an 1s earn ave 
and Cellular Therapeutics 
made significant progress in 
developing new technologies 
facility on the St. Paul 
campus. 
Frank Cerra, M.D., 
provost of the Academic 
Health Center, has made 
the Biotherapy Institute 
for the treatment of leukemia, 
other cancers, and diseases of 
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the immune system. one of his top priorities. "I 
am very supportive of the 
Biotherapy Institute because of its strategy of 
developing targeted therapies for many different 
types of diseases and disorders," says Cerra. "Dr. 
Uckun has assembled a team of excellent scien-
tists focused on designing new drugs that attack 
diseased cells while sparing the patient's healthy 
tissue and organs. This is an exciting approach for 
both patients and their physicians, because it has 
great potential for reducing both the morbidity 
and mortality caused by life-threatening disease." 
The team of researchers at the Institute has 
come from institutions throughout the United 
States and the world, bringing the latest know-
ledge of genetic, molecular, cellular, and systemic 
disease processes to suggest new strategies for 
rational drug design (see faculty list). 
"I am excited to have this strong team work-
ing together," says Uckun, "and I believe the 
future holds many promising discoveries in bio-
therapy." 
Uckun and his team have made significant 
progress in developing new technologies for the 
treatment of leukemia, other cancers, and dis-
eases of the immune system. One technology is 
the development of immunotoxins- monoclon-
al antibodies conjugated with toxins. The mono-
clonal antibodies target specific cells, allowing 
the toxins to kill cancer cells without harming 
normal cells. 
These unique forms of biotherapy have 
shown clear advantages over conventional treat-
ments. Often these new methods are the only 
hope for patients who can no longer be helped by 
standard treatments. 
"The most exciting prospect for biotherapy is 
that it will allow physicians to target and eradi-
cate abnormal cells without disturbing nearby 
healthy tissues," says Uckun. "The results of bio-
therapy studies will not only be improved therapy 
for patients unable to benefit from standard 
chemotherapy and irradiation, but potentially a 
superior form of treatment for newly diagnosed 
cases as well." 
Patients are referred to the Biotherapy 
Institute by their physicians when their illnesses 
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can no longer be controlled by standard 
methods. Conventional drugs may influ-
ence the disease outcome, but they have 
had either limited efficacy or debilitating 
short-term and long-term side effects. 
Support from Variety 
Children's Association 
Variety Children's Association (VCA) is 
supporting the Biotherapy Institute at the 
University of Minnesota through fund-rais-
ing campaigns and other efforts of its 
donors and volunteers. George Reilly, VCA 
board president, says the Biotherapy 
Institute is an innovative and effective pro-
gram designed to treat the most devastating 
childhood diseases. 
"This represents a major opportunity 
for Variety to help in providing care for crit-
ically and chronically ill children in the 
most effective way," says Reilly. "We are 
very excited about the future of this area of 
research and treatment, and what it means 
for children and their families." 
Working Together 
The Biotherapy Institute maintains strong 
relationships with many other departments 
within the University of Minnesota, pro-
viding a forum for the sharing of ideas and 
research. 
any Faras, M.D., director 
of the Institute of Human 
Hannah's 
Story 
H annahRose Schaefer is typical of 
toddlers her age. But 
this energetic little 
girl has been through a lot more than 
most children. Hannah 
Schaefer and her In January of 1995, during a routine brothers Andrew (left), and Ryan. 
visit to her pediatrician, Hannah was 
diagnosed with infant leukemia. She was nine months old. Today, thanks to 
a supportive group of medical professionals and a drug developed at the 
Biotherapy Institute, Hannah has been in remission for more than a year. 
The treatment of leukemia is one of medicine's success stories. Twenty 
or 30 years ago there were few leukemia survivors, yet today 70 percent of 
leukemia patients survive the disease. But Hannah had a type of Acute 
Lymphoblastic Leukemia (ALL) which is very difficult to treat, and her initial 
outlook was grim at best. 
Hannah's treatment began immediately after diagnosis. Within an hour 
she was receiving a blood transfusion, and the following day she underwent 
chemotherapy. When Hannah did not respond to the chemotherapy, her 
treatment was intensified. 
The chemotherapy did not remove all the cancer cells in Hannah's body, 
and the family was told about biotherapy. They learned that the therapy 
could reduce the number of leukemic cells in her body so that chemothera-
py could give her a better chance for extended survival. 
The biotherapy Hannah received involves a plant toxin hooked to an 
antibody that selectively destroys leukemia cells while avoiding normal cells. 
Hannah was eligible for this treatment because of her type of cancer. 
In April of 1995 Hannah received two rounds of treatment, and in 
October no detectable cancer cells were left. Her prognosis for a cancer-free 
future is good. 
Genetics, believes that 
Biotherapy and Human Genetics 
will have many opportunities to collaborate. 
"These may range from the identification and 
synthesis of genetic and molecular markers to 
serve as targets for biotherapy, to collaboration in 
producing gene therapy and biotherapy agents at 
the University's Molecular and Cellular 
Therapeutics faci lity." 
several new agents which show great potential as 
anti-rejection drugs. "The development of new 
immunosuppressive agents with fewer toxicities 
than those in current use wi ll be a tremendous 
advance, but the potential payoff is even bigger," 
says David Sutherland, M.D., director of 
Transplant Surgery. "If used strategically at the 
time of stimulation of an immune response, the 
new agents may induce tolerance, eliminating the 
need for long-term maintenance immunosuppres-
sion all together." 
Biotherapy Institute researchers are also col-
laborating with the University of Minnesota 
Bone Marrow Transplant Program - a relation-
ship that has been ongoing for a decade. 
Another important relationship ex ists 
between Biotherapy and the (organ) Transplant 
Program. The Biotherapy Institute has developed 
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Biotherapy is also of great importance to the 
clinical Pancreas and Bowel Transplant Programs. 
Rainer Gruessner, M.D., director of the Bowel 
Transplant Program, says, "To reduce the rate of 
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rejection, we have to be involved in the develop-
ment of new drugs that may result in improving 
graft and patient survival." 
Ongoing Research 
Faculty of the Biotherapy Institute are involved in 
numerous research projects, including the follow-
ing innovative studies. 
Battling HIV The Biotherapy Institute has 
developed a drug which may prove effective 
against HIV, the AIDS virus. The "magic bullet" 
uses monoclonal antibodies - tailor-made ver-
sions of the body's own germ-fighting antibodies. 
These monoclonal antibodies target the T-lym-
Patients are referred to 
the Biotherapy Institute by their 
phocyte white blood cells 
where HIV lives and mul-
tiplies. The antibodies are 
coupled with an antiviral 
agent derived from the 
pokeweed plant that inac-
tivates HIV. When used 
together, the pokeweed 
protein and the monoclon-
physicians when their illness 
can no longer be controlled 
by standard methods. 
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al antibodies become very potent. The hope is 
that the drug can keep the infection ftom spread-
ing to more T- lymphocyte white blood cells and 
eventually killing them. 
Childhood cancer B43-PAP is a promis-
ing new biotherapeutic agent directed against the 
most common form of childhood cancer. B43-
PAP binds to the CD19 target found on the sur-
face of leukemia cells. It becomes internalized and 
the toxin moiety is released to inactivate ribo-
somes and shut down protein synthesis. The irre-
versible inactivation of protein synthesis leads to 
rapid cell death. 
Innovative agents TP3-PAP is a new 
anti-osteosarcoma agent. 
Inside a research lab at the 
Biotherapy Institute. 
TXU-PAP is a novel anti-
AIDS drug which studies have 
shown to be 500,000-fold more 
potent than AZT. TXU-PAP also 
has potential as an effective drug 
against organ rejection in solid 
organ transplantation. 
DT-GMCSF is a fusion toxin 
for the treatment of acute myelo-
cytic leukemia (AML). AML is the 
most common form of acute leukemia in adults 
and the second most frequent leukemia in chil-
dren. DT-GMCSF therapy was proven superior to 
standard chemotherapeutic agents when tested in 
mice transplanted with an otherwise invariably 
fatal human AML. 
EGF-Genistein is a new anti-breast cancer 
agent. This agent targets the soybean-derived 
inhibitor Genistein (Gen) to the epidermal 
growth factor receptor (EGF-R) on breast cancer 
cells. In mice and monkey studies, EGF-Gen was 
more effective than standard chemotherapeutic 
drugs and resulted in 60 percent long-term can-
cer-free survival from an otherwise invariably fatal 
metastatic breast cancer. In addition to breast 
cancer, this agent will be used for the treatment of 
ovarian, bladder, and prostate cancer and 
melanoma patients. It is expected that EGF-Gen 
will be available for use in human clinical trials in 
March, 1997. 
Leukemia smart bomb The "smart 
bomb" developed by Biotherapy Institute scien-
tists is called B43-Gen. It showed promising 
results when tested in mice against B-cell precur-
sor leukemia, the most common form of child-
hood cancer and second most common form of 
adult acute leukemia. B43-Gen binds to and inac-
tivates a life-maintaining structure found on the 
surface of leukemia cells. Therefore, B43-Gen 
kills leukemia cells without harming normal cells. 
It is also a potent destroyer of lymphoma cells. 
Dr. Fatih Uckun: 
Breaking Barriers 
Uckun has gained international recognition for 
his innovative approach to treating leukemia in 
children. As a professor in the Departments of 
Pediatrics, Therapeutic Radiology-Radiation On-
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cology, and Pharmacology, he is focusing 
his research on signal transduction and 
experimental therapeutics. Uckun's work 
has provided the basis for developing novel 
therapeutic strategies for the treatment of 
AIDS, autoimmune diseases, and cancer. 
ckun has been named 
the first holder of the 
Hughes Chair in Bio-
therapy. The chair was 
made possible by gifts 
from the Variety Children's Association 
and B. Wayne Hughes of Glendale, 
California. Hughes' interest in the 
Biotherapy Institute began two years ago 
during his son's battle with cancer. His son 
received biotherapy treatment from 
Uckun and his team and is doing well. 
Uckun has been awarded a number of 
research grants from the National 
Institutes of Health, the Leukemia Society 
of America, and the Department of 
Defense. He is the holder of 11 patents, 
and has 250 publications to his credit. 
The Biotherapy Institute faculty 
includes: 
Dr. Yulong Chen, a bioorganic chemist 
from Harvard University Medical School. 
He plays a key role in rational design and 
synthesis of therapeutics to help patients 
suffering from cancer, AIDS, and cardio-
vascular diseases. 
Dr. llker Dibirdik, a biochemist from the 
A bright future 
A t the age of 13, Lance Reiland of Alberta, Canada, formed the Theatre Arts Community Outreach Society, a musical dance theatre company which provides performing and cultural 
exchange opportunities for Canadian students of Russian classical dance. Just 
a few years later, he received a 
grant from the Canadian 
Native Arts Foundation to 
study Russian classical dance in 
the Czech Republic. 
Lance has accomplished a 
great deal for a 17-year-old, 
but his biggest challenge is 
beating Acute Lymphoblastic 
Leukemia (ALL), diagnosed this 
past summer. He was studying 
at the Royal Winnipeg Ballet 
School at the time, and 
returned home to Alberta for 
chemotherapy treatment. 
After learning about bio-
therapy treatment at the Uni-
versity of Minnesota, Lance's 
parents decided that's where 
lance Reiland with his pediatric oncologist, 
Dr. Yoav Messinger. 
he should be - despite the fact that the treatment was not covered by the 
Canadian health care system. 
Lance received biotherapy treatment beginning in October, followed by 
a bone marrow transplant in November. The application of biotherapy treat-
ment prior to bone marrow transplantation was performed to increase the 
chance of survival by eliminating leukemia cells that are resistant to bone 
marrow transplant therapy. 
The biotherapy treatment has given Lance and his family renewed hope 
for the future. He has developed an interest in medicine after getting to 
know the staff of the Biotherapy Institute, but his first love is still dance. 
Cellular Immunity and Tissue Culture 
Laboratory at Gulhane Military Medical School 
in Ankara, Turkey. His research focuses on cellu-
lar and humoral immunity, cancer biology, and 
molecular biology with particular emphasis on sig-
nal transduction in leukemic cells and their nor-
mal counterparts. 
Mahajan has been named a Variety Research Scholar. 
Dr. Zahide Ozer, a chemist from the University 
of North Carolina at Chapel Hill, who received 
her Ph.D. from Middle East Technical University 
in Ankara, Turkey. She is continuing her work on 
DNA damage control and repair. 
Dr. Sandeep Mahajan, a molecular biologist 
from the Drug Discovery Program of Bristol-Myers 
Squibb. He is part of a team of 10 molecular biolo-
gists and biochemists working to elucidate the key 
signal transduction events in hu-man lympho-
cytes and lymphocyte precursors. While at Bristol-
Myers Squibb, he successfully cloned several criti-
cal genes that have pivotal roles in cell survival. 
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Dr. Jong-Sung Park. a microbiologist from the 
University of Alberta in Edmonton, Canada, who 
received his Ph.D. from the Kyung Pook National 
University in Korea. He is focusing his efforts on 
developing novel strategies to slow down the 
aging process and designing new preventive mea-
sures against cancer. 
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Dr. Alexander Rostovtsev, a biochemist who 
received his Ph.D. from Moscow University. He 
focuses his research efforts on identification, 
purification, and characterization of cancer cell 
associated antigens. 
Dr. li-Yan Sun, a plant biologist who received 
her Ph.D. from the University of Paris. She is 
studying transgenic plants and plant derived 
active ingredients that will be utilized in rational 
drug design efforts. 
Dr. Kevin G. Waddick, from the Department of 
Biophysical Sciences at the University of Min-
nesota. He is studying immunology as it pertains to 
The most exciting prospect 
for biotherapy is that it will 
radiation therapy and 
alternative means of induc-
ing apoptosis in leukemia 
cells. 
allow physicians to target and 
eradicate abnormal cells 
without disturbing nearby 
healthy tissues. 
Dr. Bruce Witthuhn, a 
biochemist from St. Jude 
Children's Hospital in 
Memphis. He focuses his 
research efforts on molecu-
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lar events triggered by cytokines and hormones. 
Witthuhn has been named a Variety Research 
Scholar. 
Dr. Carla Wood, a microbiologist from the Uni-
versity of Warwick in the United Kingdom. She is 
studying the impact of aging and the risk of devel-
oping cancer. She received training in aging in 
the laboratory of molecular genetics at the 
National Institute on Aging, Baltimore. 
Dr. Jun Xiao, from the Medical School of Shan-
dong Medical University in China, who did post-
doctoral training in cellular immunology, bio-
chemistry, molecular bio logy, and molecular 
immunology. She is researching human breast 
cancer and immunodeficiencies. 
Dr. Lance Augustin, a biochemist from the 
Pharmacology Department at the University of 
Minnesota. He investigates molecular mecha-
nisms underlying chemical and radiation induced 
For more information about the Biotherapy Institute, 
visit the website at: http://www.biotherapy.umn.edu. 
changes in gene expression. Molecular interac-
tions identified in these studies will be targeted by 
agents designed to increase the efficacy of anti-
cancer therapies. 
Dr. Alexey Benyumov, from Moscow State 
University, where he was a senior research scien-
tist in the Department of Embryology. His 
research interests are in the field of developmen-
tal and cell biology performed in the studies of 
nuclear reprogramming and gene transfer in fish. 
He studies mitotic cell division regulation inver-
tebrates using zebrafish embryonic development 
as a model system. 
Dr. Patricia Goodman, a geneticist from the 
University of California at Los Angeles. She per-
forms molecular genetic studies of ataxia telang-
iectasia. This genetic disorder is complex since 
patients have neurologic and immunological 
defects as well as an increased cancer risk. She is 
also involved in molecular genetic analysis of 
other immune disorders. 
Dr. Alexei Vassilev, a biochemist from the 
Department of Cell Biology and Neuroanatomy 
at the University of Minnesota. He works on 
characterization of a regulatory system that halts 
the cell cycle in response to microtubule pertur-
bation or DNA damage. 
Dr. Mark Williams, a biochemist from the 
BioProcess Technology Institute at the University 
of Minnesota. He has extensive experience in 
bacterial and baculovirus/insect cell protein expres-
sion systems and is particularly interested in the 
optimization of such systems. He uses his experi-
ence to develop protein expression systems for poten-
tial therapeutic proteins and immunoconjugates. 
Dr. Yoav Messinger, a pediatric oncologist, 
who treats high-risk leukemia patients on experi-
mental Phase I or Phase II clinical protocols. He 
was the first fellow to be trained in the Biotherapy 
clinical service and has played a pivotal role in 
implementation of new treatment programs. 
Messinger was named the first Variety C linical 
Scholar. • 
Editor's note: Thanks to the Biotherapy Institute's 
"Discoveries" publication and Variety Children's 
Association's "Billboard" for in[orrrultion included in 
this article . 
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Investing in the Future: Focus on Scholarships 
Class Gifts Scholarships 
lass reunions, particu-
larly 50-year class re-
unions, often height-
en the sense of time 
passing. For many alumni, the reunions 
are a time to reminisce, reunite with 
friends, and contemplate the future. 
In gratitude for the education they 
received and to perpetuate the legacy of 
giving and helping, members of a class 
year often create a scholarship fund. As 
Dr. Peggy Craig, '45, explains, "We give 
class gifts to help the students coming 
along, but more importantly, it is a recog-
nition. It is our recognition of what we have gained be-
cause we went to medical school, and in many instances 
somebody helped us. We never die:! it alone. It was either 
our parents, our employer, or somebody else who helped 
us. " 
Often, those who receive scholarships later give in 
return. "The scholarships prepare the current medical stu-
dents to give to those who come behind them. It shows 
that this is a profession we are very proud of and they 
should have the same pride and same responsibility to it," 
says Craig. 
Many alumni also feel a sense of obligation to the 
future classes of medical students. With the continued rise 
in tuition, it is increasingly difficult for students to finance 
their education. Annual tuition for Minnesota residents is 
$16,300 and tuition for non-residents is $29,700. The 
average medical student debt at graduation is $67,000. 
In fiscal year 1996, 2, 736 alumni contributed a total 
of $2,093,642 to the Minnesota Medical Foundation in 
support of the Medical Schools in the Twin C ities and 
Duluth. The percent of reachable class members giving 
ranged from 8 percent to 41 percent for each class. 
"Giving to the class fund tends to rekindle the feelings 
from medical school," says Dr. Richard McGraw, '43. "It's 
a feeling of connectedness or giving together." 
As chair of her reunion committee, Craig notified 
and encouraged her colleagues to contribute to the fund. 
In addition, she tried to instill the feeling that giving is not 
simply an obligation but also a great privilege. It is an 
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Members of the Class of 1945. 
opportunity to pay back some of the help that is given 
along the way. It is, as McGraw says, "The maintenance 
of the world." • 
A Critical Need 
T here is a critical need for scholarships for medical students. In order to main-tain the high quality of physicians grad-
uating from the University of Minnesota Medical 
Schools, the Minnesota Medical Foundation has 
made scholarship support a top priority. The 
Minnesota Medical Foundation board of trustees 
is committed to increasing scholarship support to 
medical students by 20 percent annually by rais-
ing a minimum of $3 million to add to scholar-
ship endowments by the end of fiscal year 1998. 
In the past year, the Minnesota Medical 
Foundation presented 263 individual scholar-
ships totaling $290,550. In each issue of the 
Medical Bulletin we profile a scholarship cur-
rently given through the Minnesota Medical 
Foundation. 
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MEDICAL SCHOOL NEWSBRIEFS 
Dean's Report 
T hese are remarkable times for our Medical School. The revolution in health care management - now in full bloom in Minnesota -has had a major impact on how we practice 
medicine and how we teach its art and sciences. In 
response to these imperatives for change, a strong 
Academic Health Center is in place linking the goals 
and directions of the Medical School to its sibling 
health science schools/colleges where we have much 
in common for the development of joint educational 
and scientific programs that benefit all students and 
programs concerned with health. 
The recent formation of the Fairview-University 
Medical Center provides a strong clinical base for the 
care of patients by Medical School faculty and com-
munity-based physicians. In addition, the depart-
mental practice plans have combined into a single 
group practice in order to provide comprehensive 
care in our changing health care environment. 
However, the Medical School with its educational 
and research missions is clearly separate from any 
specific health system and will continue as an educa-
tional and research engine for the state by maintain-
ing and developing relationships with all physicians, 
hospital, and health care networks. 
This "community model" is reflected by our numer-
ous partnerships with physicians, hospitals, and 
health systems providing superlative education for 
our students and residents. The secret of the Medical 
School's success lies in continuing to foster these 
relationships. We will be reviewed by the Liaison 
Committee on Medical Education in the spring of 
1997 and I predict our excellent educational program 
will fare very well in this review. 
Innovation and research are important goals for the 
School for we are also challenged to look into the 
future and develop new ways to solve the riddles of 
disease. Our basic science programs are vigorous and 
we are developing new ways to connect basic science 
investigators to the clinical arenas and to connect 
programs across the entire University. Our second 
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Alfred E Michael, M.D. 
revolution deals 
with molecular 
science, structural 
biology, and 
remarkable 
advances that will 
teach us more 
about the body and 
the medicine of 
the future. 
The excellence of our research program is reflected 
by the resources obtained by the faculty from the 
National Institutes of Health and other organizations 
ranking us 16th in the nation. C linical research is an 
every day occurrence in our Medical School. 
Minnesota's first surgical remodeling of the heart to 
treat cardiomyopathy was recently performed by Drs. 
Chip Bolman and Soon Park - a procedure that 
may be an alternative to heart transplants. A toddler 
from Northern Minnesota received part of her 
father's liver in a rare operation performed by Dr. 
Rainer Gruessner, and a three-year-old girl was the 
recipient of Minnesota's first small bowel and liver 
transplant. These and many other programs are 
initiated by research. 
A recent survey conducted by our Medical School 
showed that more than half of the Medical School 
students who graduated in 1985 are practicing in 
Minnesota, with 60 percent of those graduates in 
family practice. We are way ahead of the national 
average for students entering primary care medicine. 
We also look forward to Mark Yudof's arrival on 
campus, and know he is a strong supporter of the 
Medical School. We want you to know that we are 
not just alive and well. This is a superb Medical 
School that takes up the challenge and looks forward 
to the future. 
Alfred F. Michael, M.D. 
Interim Dean 
University of Minnesota Medical School, Twin Cities 
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Mark Yudof named 14th 
president of the University 
of Minnesota 
M ark Yudof, execu-
tive vice president and 
provost of the University 
of Texas at Austin since 
1994, was named the 
14th president of the 
University of Minnesota 
on December 13 by a 
unanimous vote of the 
board of regents. Yudof, 
52, will assume the post 
July 1, 1997, upon the 
retirement of University Mark Yudof 
President Nils Hasselmo, 
who has served since 1989. 
Yudof has a bachelor's degree from the University of 
Pennsylvania and a law degree from the University of 
Pennsylvania Law School. He served for 10 years as dean 
of the University of Texas School of Law before becom-
ing executive vice president and provost. In that post, he 
initiated many improvements in undergraduate educa-
tion at the A ustin campus, including an extensive revi-
sion of undergraduate advising; an Academy of 
Distinguished Teachers to recognize and reward out-
standing teachers, especially those who teach undergrad-
uates; and a freshman seminar program that aims to give 
all entering freshmen a small-class experience. 
As an administrator, Yudof has a reputation for com-
mitment to scholarship. While dean of the University of 
Texas School of Law, he created - and raised funding 
for - a program to allow regular sabbaticals to faculty 
wishing to pursue scholarly activities. In his personal 
legal work, he is an authority on school finance and has 
written widely on such topics as school desegregation 
and property taxes. Yudof is a fellow of the American Bar 
Foundation and the Texas Bar Foundation and holds the 
James A. Elkins Centennial Chair in Law at the 
University of Texas. • 
University moves to forefront 
of umbilical cord blood 
transplant research 
The University of Minnesota Blood and Marrow 
Transplant (BMT) Program has been designated 
a National Heart Lung Blood Institute (NHLBI) trans-
plant center in a multimillion dollar national effort to 
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expand the applications of umbilical cord blood trans-
plantation , a promising treatment for deadly blood dis-
eases. 
The $727,000 contract, plus part of the BMT 
Program's $5 million National Institutes of Health 
(NIH) grant to study alternative sources of stem cells, 
moves the University of Minnesota to the forefront of 
research that will expand and improve this highly 
promising therapy, according to Dr. John Wagner, the 
BMT Program's associate director. The NHLBI study, 
which includes five other institutions, is based signifi-
cantly on Wagner's previous research. 
To date, 25 cord blood transplants have been per-
formed at the University of Minnesota, placing it among 
the top two institutions in the world that are advancing 
this therapy. Under the new NHLBI program, approxi-
mately 350 transplants will be performed at all six insti-
tutions involved in the study with cord blood from three 
NHLBI-funded banks. 
The BMT Program cord blood transplant team aims 
to determine if cord blood contains adequate numbers of 
stem cells to take hold and multiply in adult-sized trans-
plant patients, thereby extending the therapy's applica-
bility. The NIH stem cell grant is funding efforts to 
expand umbilical cord blood stem cells in the laboratory, 
in order to increase the number of cells available for 
transplant and to shorten hospitalization. The transplant 
team will also explore the incidence and severity of com-
plications associated with unrelated bone marrow trans-
plantation, such as graft-versus-host disease and infec-
tions. Finally, based on groundbreaking work by the 
BMT Program, this study will explore quality of life and 
cost issues associated with umbilical cord blood trans-
plantation. • 
Thompson aJ?pointed 
vice provost tor clinical affairs 
Dr. Roby Thompson, Jr. has been appointed vice 
provost for clinical affairs in the Academic Health 
Center. As vice provost, Thompson plays a major role in 
implementing the affiliation with the Fairview Health 
System. 
He continues to practice orthopaedic surgery, with 
emphases in the areas of bone and soft tissue tumors. He 
has been responsible for the training program in 
orthopaedic surgery and served as department head for 
20 years. During his tenure, the department and its edu-
cation and research programs have achieved world-class 
stature and recognition. • 
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DEPARTMENTAL UPDATES 
Biochemistry 
Dr. Paul Siliciarw was promoted to associate professor 
July 1. Dr. Ian Armitage, professor, received a $539,140 
National Institutes of Health (NIH) grant for 
"Multinuclear NMR probes of biological systems." He 
also received a $71 2,266 National Science Foundation 
(NSF) grant for "Establishment of a high field nuclear 
magnetic resonance facility." Dr. Vivian Bardwell, 
assistant professor, was awarded $20,000 from the 
Leukemia Task Force for "Gene regulation by BCL-6." 
Dr. Laura Mauro, assistant professor, received an NIH 
Shannon Award of $80,000 for "Function of tyrosine 
phosphatase, OST PTP, in osteogenesis." Dr. Kevin 
Mayo, associate professor, received a $47,976 grant for 
the production of two segments on the PBS-TV series 
"Newton's Apple." Mayo also received a $3 7,469 NIH 
grant for "Liver sterol carrier proteins: Effects of ethanol." 
Dr. Howard Towle, professor, received a $556,690 NIH 
grant for "Nutritional and hormonal regulation of hepat-
ic genes." 
Dermatology 
Dr. Saganika Kanjilal has joined the department. 
Dr. Mark Dahl, professor and head, attended dedication 
ceremonies of the new Dermatology Clinic{rraining 
Center Building in Moshi, Tanzania, which provides 
training to medical assistants from 12 African countries. 
Dr. Marna Ericson, assistant professor, joined the 
department as the director of laboratory research. She is 
currently researching alopecia areata, hair loss in women, 
the peripheral nervous system, and photodynamic thera-
py as a treatment for skin cancer. Dr. Whitney Tope, 
assistant professor, received approval for research on oral 
delta-aminolevulinic acid for photodynamic therapy of 
basal cell carcinoma. 
Family Practice and 
Community Health 
Dr. William E. Jacott, associate professor and interim 
head, was elected vice chair of the board of commission-
ers of the Joint Commission on Accreditation of Health 
Care O rganizations. 
Medicine 
Dr. Harry S. Jacob, professor and holder of the 
George C lark Professorship in Medicine, vice president 
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and head of the Division of Hematology, was elected a 
fellow of the American Association for the 
Advancement of Science for his research in blood vessel 
and blood cell disorders. He was also elected president of 
the American Society of Hematology. Drs. John Bantle, 
professor, and Bruce Redman, assistant professor, are co-
principal investigators in research involving a pharmaco-
logic induction of weight loss to treat Type II diabetes 
mellitus. The study is funded by the American Diabetes 
Association. Redman also spoke about obesity 
management at the 21st Annual Fall Seminar of the 
Minnesota Academy of Physician Assistants. Dr. Tim 
Schacker, assistant professor and medical director of the 
University of Minnesota HIV C linic, is conducting an 
ongoing study on the virology of primary HIV infection. 
He has established a clinical research project to evaluate 
patients who fail to respond to conventional antiretrovi-
ral therapy, and has created a clinical research database 
to support HIV studies. Dr. (]reg Vercellotti, professor, 
has been appointed vice chair for education. He is also 
the new host of "Health Talk and You." Dr. Craig 
Henke, assistant professor, is conducting a study to 
examine the mechanisms of lung repair. He also 
received an American Heart Association G rant-In-Aid 
to examine new antifibrosis therapies. Dr. Elizabeth 
Seaquist, associate professor, received a grant from the 
Juvenile Diabetes Foundation to measure the glucose 
homeostasis in the human brain by Nuclear Magnetic 
Resonance. She was also appointed consultant to the 
Science Museum of Minnesota. Monica Overkamp, 
ANP, lectured on travel medicine in November at St. 
O laf College and the College of St. Catherine. Dr. 
Jianyi Zhang, senior research associate, received a 
$300,000 American Heart Association (National) 
Established Investigator Award to examine the relation-
ships between myocardial oxygenation, bioenergetics, 
and contractile function in hearts with severe left ven-
tricular remodeling secondary to left circumflex coronary 
artery occlusion. Dr. Keith M. Skubitz, associate profes-
sor, was chair of the 6th International Workshop and 
Conference on Human Leukocyte Differentiation 
Antigens in November in Kobe, Japan. He was also an 
invited speaker at the 7th International CEA/PSG 
Workshop in Los Angeles in September. Sue Fred-
strom, clinical nutritionist, is researching the interdepen-
dence of hemodynamic immunologic and metabolic 
derangements of liver disease. Dr. P.N. Yaks he, assis-
tant professor, is investigating the role of antioxidants in 
relieving oxidative stress in chronic pancreatitis. Dr. 
Gladwin Das, assistant professor of pediatrics, is evaluat-
ing a new percutaneous device used to treat atrial septal 
defects, or holes in the heart. 
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Neurology 
Dr. Gareth Parry, professor and chair, was elected to 
the Faculty Practice Organization Board of Directors for 
a three-year term. The following faculty have joined the 
department: Dr. Desiree Czapansky-Beilman, assistant 
professor, Division of Pediatric Neurology; Dr. Sara 
Langer, assistant professor, directs both the Neurology 
Outpatient C linic and the Neurology Residency 
Program; and Dr. Praful Kelkar, assistant professor, who 
has joined the neuromuscular group and will be involved 
in the Neuromuscular C linic and research of treatment 
protocols. Dr. Paul Tuite, assistant professor, has estab-
lished a Movement Disorder C linic at the Academic 
Health Center, and is developing a comprehensive pro-
gram on the diagnosis and treatment of Parkinson's 
disease. 
Dr. Costantirw Iadecola, associate professor and 
associate head for research, and Dr. M. Elizabeth Ross, 
associate professor, received a $82 7,517 NIH grant to 
research the molecular mechanisms responsible for stroke 
and for devising new treatment therapies. Drs. Gareth 
Parry and Praful Kelkar were awarded research grants 
from Amgen to study new treatments for Lou Gehrig's 
disease and diabetic neuropathy using growth factors. 
Drs. Ross and William Dobyns, associate professor, 
received a $703,433 NIH grant to identify and study the 
gene responsible for a human developmental disorder of 
neuronal migration. Dr. David Rottenberg, professor of 
neurology and radiology, chief of the Neurology Service 
and director of the PET Imaging Service at the 
Minneapolis VA Medical Center, has been awarded a 
Program Project Grant from the NIH to use positron 
emission tomography and functional magnetic 
resonance imaging to study human brain function. The 
study is part of a larger program called the Human Brain 
Project. O thers involved include Drs. Seong-Gi Kim, 
assistant professor of radiology, Stephen C. Strother, 
associate professor of radiology and neurology, John J. 
Sidtis, associate professor, and Lael C. Gatewood, profes-
sor of laboratory medicine and pathology. 
Otolaryngology 
Dr. David Hom received a $480,000 NIH FIRST 
(First Independent Research Support and Transition) 
Award for "Impaired soft tissue wound healing with 
growth factors." Hom was also promoted to associate pro-
fessor. Dr. Peter Santi was promoted to full professor and 
Dr. GeorgeS. Goding, Jr., was promoted to associate 
professor. 
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Pediatrics 
Dr. C. Carlyle Clawson, professor, was named medical 
director of the Neighborhood Health Care Network, a 
management services organization for community clinics 
in the Twin C ities area. He will coordinate program 
expansions and develop new procedures for the 
Continuous Quality Improvement Department. 
Pharmacology 
Drs. Stan Thayer, associate professor, and Horace 
Loh, department head and holder of the Frederick and 
Alice Stark Neuroscience Chair, received a $369,837 
three-year NIH grant to study opioid excitatory signaling. 
Dr. Earl Dunham, associate professor of medicinal 
chemistry, was elected a fellow of the Council for High 
Blood Pressure Research of the A merican Heart 
Association. Dr. S. Ramakrishnan received a $100,000 
two-year grant from the G ustavus Louise Pfeiffer 
Research Foundation to investigate the effect of antibod-
ies to vascular endothelial growth factor on ovarian and 
breast cancers. Dr. Duanqing Pei was appointed assis-
tant professor. His main research interest is the turnover 
of the extracellular matrix under physiological and 
pathological conditions such as tumor metastasis. Dr. 
Stephen W. Schondelmeyer, professor and holder of the 
Century Mortar C lub Endowed Chair in Pharmaceutical 
Management and Economics, gave a presentation to the 
Presidential Advisory Council on HIV/AIDS in 
Bethesda, Maryland. He was recently named associate 
dean and director of the Division of Research and 
Graduate Programs in the College of Pharmacy. 
Physiology 
Dr. Linda Boland, assistant professor, received an NIH 
grant for research on the molecular physiology of potassi-
um channel gating. She also received an ataxia grant for 
research on ion channel defects and hereditary episodic 
ataxia. Dr. Vincent Barnett, assistant professor, received 
an NIH grant for his work on molecular and cellular 
mechanics of muscle. Dr. Martha Flanders, associate 
professor, received an N IH grant for research on the pat-
terns of muscle activity in natural arm movement. Dr. 
Apostolos Georgopoulos, professor and holder of the 
American Legion and A merican Legion Auxiliary Chair 
in Brain Science, received an NIH grant for his 
neurophysiology research on the cognitive processes in 
motor behavior. Dr. Richard Poppele, professor, 
received an NIH grant entitled "Functional localization 
in the cerebellum." Dr. John Soechting, professor, 
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Departmental Upda tes, continued 
received a Human Frontier G rant entitled "Internal 
Frames for Visuomotor Transformations." Ute 
Hermann, a neuroscience graduate student , received the 
Eva 0. Miller Fellowship. Dr. Steven Katz, associate 
professor, received the 1996 A merican Medical Women's 
Association Gender Equity Award for outstanding 
teaching. 
Surgery 
Dr. Jorge L. Rodriguez was named a vice chair and 
associate professor. He is also the chief of surgery at 
Hennepin County Medical Center. Dr. Julio Garcia-
Aguilar was named a partner of the Colon and Rectal 
Surgery Associates of St. Paul. He will also supervise the 
development of the basic science colorectal cancer 
research laboratory at the University's Cancer Center. 
Dr. Bernhard J. Hering was named an assistant profes-
sor in October. Nicole Kirch1wf, D.V.M., joined the 
faculty in October as a research associate. A veterinary 
pathologist, she is working with the Diabetes Institute 
and has a joint appointment with the Department of 
Veterinary Pathobiology. Dr. Karen R. Wasiluk was 
promoted to research associate and assistant professor 
in July. Dr. Greg J. Beilman was named the associate 
director of surgical critical care and an assistant professor 
of general surgery. Dr. David Dunn, Jay Phillips 
Professor and head of surgery, hosted the Seventh 
Annual Fundamentals of Surgical Research Course at the 
University of Minnesota on July 13-16. Dr. David A. 
Rothenberger, clinical professor and chief of the 
Division of Colon and Rectal Surgery, was named presi-
dent of the American Society of Colon and Rectal 
Surgeons. Dr. John S. Najarian, clinical professor of 
surgery and former department chair, delivered his 
Presidential Address at the XVI International Congress 
of the Transplantation Society in Barcelona, Spain, on 
August 28. He also received the second annual 
Glenn T. Sea borg Award from the Sons of California. 
Therapeutic Radiolo gy 
Dr. Seymour H. Levitt, professor and head, was given 
the G len W. Hartman Award by the Minnesota 
Radiological Society at the Fall A nnual Meeting. • 
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FOUNDATION REPORT 
Foundation welcomes new staff 
cndy J. Kaiser, CPA, has 
been appointed vice president 
of finance for the Minnesota 
Medical Foundation . Prior to 
joining the Foundation , she 
served as controller for Rehab 
O ne, Inc. She received her 
Bachelor of Science degree from 
the U niversity ofWisconsin-
La C rosse. 
Sara Jean Dougherty has 
been named associate director 
of annual giving and alumni 
relations. She was previously an 
account executive at Westmore-
land Larson Webster, Inc., in 
Duluth, Minnesota. She 
received her Bachelor of Arts 
degree from Montana State 
University. 
C. Blaine Thrasher has 
been appointed director of 
development for the Depart-
ment of Surgery. Prior to joining 
the Foundation, he was the 
deputy director for the CARE 
Foundation. He received his 
Master of Arts from Luther 
Northwestern Theological 
Seminary and his Bachelor of 
Arts from Concordia College. 
Mark Marshall has been 
named director of development 
for special programs. He has 
served the Foundation as direc-
tor of alumni relations for the 
past five years. He received his 
Bachelor of Arts degree from St. 
O laf College. • 
Cindy]. Kaiser 
Sara Jean Dougherty 
C. Blaine Thrasher 
Mark Marshall 
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Grant recipient: Elsa G. Shapiro, Ph.D. 
F aced with conflict, one child may retreat while the other lashes out. What causes some children to respond with aggression? Recent research has shown that lead may 
play a role in a child's propensity to act aggressively. 
Previously it had been shown that lead taken in 
through fumes or dust, paint chips, or water could build 
up over time and high levels of lead could cause learn-
ing, behavior, and health problems in young children. 
Knowing that their children were particularly at risk 
because they live in older housing and in a high-traffic 
corridor, people of the Minneapolis Phillips neighbor-
hood approached Amos Deinard, M.D., associate pro-
fessor of pediatrics and director of the Community-
University Health Care Center/Variety Children's 
Clinic, in 1991 seeking advice and solutions. Now the 
Minneapolis Phillips Neighborhood Lead Collabor-
ative and the University of Minnesota are tackling the 
issue of lead and children together. 
"This is a unique study," says Elsa G. Shapiro, 
Ph.D., Department of Pediatric Neurology. "The 
Phillips Neighborhood Lead Collaborative is actually 
one of the co-investigators. I think this is a model for 
how the University and a diverse, low socio-economic 
neighborhood can work together to solve a problem." 
One tactic the group is taking involves a study 
headed by Deinard to evaluate how education affects 
prevention of lead overburden (blood lead levels of 
more than 10 micrograms/deciliter). Another, led by 
Shapiro, examines how lead overburden affects atten-
tion and memory. Within that study, Shapiro is also 
evaluating the role of lead in aggressive behavior in 
children. 
"We know from our clinical work and other 
research that lead-burdened children have more learn-
ing difficulties, are more aggressive, and show attention 
problems," says Shapiro. "That is why we are looking at 
how lead overburden affects attention and memory, 
and now, aggressive behavior. This involves following 
children from the Phillips Neighborhood from birth 
through five years of life. 
"Initially we thought the aggressive behavior 
might be the byproduct of memory and attention prob-
lems and not something lead itself affected," she says. 
"Then we began thinking about how lead might affect 
the propensity to act aggressively, how it may alter the 
threshold for aggressive behavior in children. We 
decided we wanted to use the same group of children to 
add a bit to the study and examine aggressive behavior." 
The group received additional funding for one year 
from the Minnesota Medical Foundation's Emma B. 
Howe fund to look at aggressive behavior and lead 
overburden (original funding for the project came from 
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Elsa G· Shapiro, Ph.D. 
Maternal and Child Health for the educational inter-
vention project "Does Education Limit Lead Burden?") 
Shapiro also received a one-year $7,000 grant from the 
Foundation to fund another aspect of the research into 
aggressive behavior. She is one of 11 faculty members to 
receive $73,215 in grants from the Foundation last fall. 
"We realized we needed some sort of biologic 
marker of aggressive behavior. If we thought the behavior 
was affected by lead burden we had to have some way of 
measuring it biologically," explains Shapiro. With Dr. 
Megan Gunner, Institute of Child Development, Sha-
piro decided that measuring the hormone cortisol may 
give an indication about lead's link to aggressive behavior. 
"Cortisol is involved in regulating emotional 
arousal and is implicated in attention and memory," 
says Shapiro. To obtain cortisol in a saliva sample, the 
children are given sugar-coated gauze to suck. A base 
measurement will be taken and for a measurement of 
aggressive response, the children will be gently pro-
voked before another sample is taken. Shapiro hopes to 
be able to show a link between the cortisol levels and 
elevated lead levels. 
"We are currently writing a larger grant to be sub-
mitted for federal funding for four more years. The 
money from the Foundation grant will help us provide 
data to support the grant proposal." 
Over the next five years, researchers will evaluate 
whether there is a critical point in development when 
elevated lead levels may be more damaging or whether 
long durations of lead overburden are as damaging as 
short-term high levels. 
"This is the only project of its type," says Shapiro. 
''Not only in the way the neighborhood is involved but 
also in d"le way we are looking at the effects of lead overbur-
den on growth and development. It's very exciting." • 
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UMD scholarships presented 
S cholarships presented during the 1995-96 academic 
year to University of Minnesota, Duluth, School of 
Medicine students were inadvertently omitted from the 
Minnesota Medical Foundation's 1996 Annual Report. 
Names of recipients and the scholarships they received 
are listed below. We apologize for this error. 
Charles and Ruth 
Bagley Scholarships 
Timothy Arnold 
Allison Heimer 
Mollie Stapleton 
ThoTTUlS Viren 
Established by Dr. and 
Mrs. Bagley to benefit sec-
ond-year medical students 
at the University of 
Minnesota, Duluth. 
Duluth Clinic 
Regional Scholarships 
Kris ten Fallstrom 
Nichole Hecimovich 
Provided by physicians at 
the Duluth C lin ic to 
benefit University of 
Minnesota, Duluth, 
medical students. 
Ben and Jeanne 
Overman Scholarships 
Timothy Arnold 
Seth Larson 
Provided by the Ben and 
Jeanne Overman 
Charitable Trust to bene-
fit medical students at the 
University of Minnesota, 
Duluth. 
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John George Ross 
Scholarships 
Joshua Crabtree 
Joel Erickson 
Monte Johnson 
Wendy Johnston 
Matthew Kirsch 
Jay Kruse 
KhoaLe 
Nathan Norquist 
Created by bequest of 
John George Ross. 
UMD Scholarships 
Amy Colwell 
David Hajek 
Michael Hudalla 
Kari Johnson 
Peter Sandgren 
Sandy Schumacher 
Established during the 
Centennial Scholarship 
Campaign. 
Harold and Rhea 
Walder Memorial 
Scholarship 
David Jorde 
Established through a trust 
created by Harold Walder 
to benefit medical students 
at the University of 
Minnesota, Duluth. 
Foundation approves $2 97,7 26 
in grants 
A t its summer and fall quarterly meetings, the 
Minnesota Medical Foundation board of trustees 
approved $297,726 in research and special grants. The 
amount includes $161,715 in research grants, $129,71 1 
in special grants, and $6,300 in student grants. 
SUMMER FACULTY RESEARCH GRANTS 
include: Thomns T. Amatruda III, M.D., Medicine, 
$6,000, A program to bank viable melanoma cells for use 
in clinical treatment and clinical research; Linda M . 
Boland, Ph.D., Physiology, $8,500, Cerebellar physiolo-
gy of SCA1 transgenic mice; Kathleen F. Conklin, 
Ph.D., Microbiology, $9,000, Cell type specific activity 
of retrovirus LTRs; Earl W. Dunham, Ph.D., 
Pharmacology, $8,000, Pharmacology and medicinal 
chemistry analysis of adrenoceptor control of renin secre-
tion in mice with mutated alpha 2A andrenergic recep-
tor; Maurice W. Dysken, M.D., Psychology, $3,000, 
Plasma and red blood cell serraline and desmethylsertra-
line levels; Mary C. Gannon, Ph.D. , Medicine, $7,000, 
Liver glycogen deposition in human subjects after inges-
tion of meals; Angeliki Georgopoulos, M.D., Medicine, 
$3,000, Are genetic mutations of homocysteine metabo-
lism associated with macro angiopathy and/or nephropa-
thy?; David A. Lee, M.D., Radiology, $5,000, Male fer-
tility evaluation using penile ultrasound - comparison 
of response to papaverine versus caverject; Paul C. 
Letourneau, Ph.D., Cell Biology and Neuroanatomy, 
$9,000, Mechanisms of nerve growth turning and 
branching; Ronald C. McGlennen, M.D., Laboratory 
Medicine and Pathology, $7,000, Detection of estrogen 
receptor variant in breast tissue by in-situ hybridization; 
Dean L. Melnyk, M.D., Ph.D., Anesthesiology, 
$8,500, Modulation of stress response in a mouse sepsis 
model; Robert D. Nelson, Ph.D., Dermatology, $8,500, 
Regulation of human neutrophil chemotaxis; and 
William B. Rathbun, Ph.D., Ophthalmology, $6,000, 
Maintenance of glutathione homeostasis for prevention 
of diabetic cataracts. 
SUMMER SPECIAL GRANTS include: Greg 
Connell, Ph.D., Pharmacology, $20,000, RNA editing 
in trypanosomatids; Glenn Giesler, Jr., Ph.D., Cell 
Biology and Neuroanatomy, $18,745, Tonic currents in 
pain receptors; Arlen R. Severson, Ph.D., Anatomy 
and Cell Biology, $13,000, Neuroanatomy Laboratory: A 
computer-assisted learning program; Carol L. Wells, 
Ph.D., Laboratory Medicine and Pathology, $19,200, 
Translocating bacteria: Role in surgery and trauma; and 
David L. Dunn, M.D., Ph.D., Surgery, $4,989, 
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Immunotherapeutic protection during gram-negative 
bacterial sepsis. 
FALL FACULTY RESEARCH GRANTS 
include: M. Dwight Chen, M.D., Obstetrics and 
Gynecology, $3,000, Decay accelerating factor in the 
pathogenesis of endometrial neoplasms; Charles E. 
Dean, M.D., Psychiatry, $5,000, Instrumental and clini-
cal assessment of tardive dyskinesia; Marshall L. Hertz, 
M.D., Medicine, $8,000, Inhibition of airway fibrosis 
with synthetic fibronectin peptides after tracheal trans-
plantation; Kristin A. Hogquist, Ph.D., Laboratory 
Medicine and Pathology, $6,075, Positive selection of T 
cells in vitro; Stephen C. Jameson, Laboratory Medicine 
and Pathology, $6,700, Controlling T cell responses with 
oligonucleotides; Jose Jessurun, M.D., Laboratory 
Medicine and Pathology, $6,000, Detection of K-ras 
mutations in samples from ERCP washings and brush-
ings, CT guided needle biopsies, and resected pancreas 
specimens to aid in the detection of pancreatic and bil-
iary adenocarcimonas; David C. LaPorte, Ph.D., 
Biochemistry, $9,800, Target protein recognition in the 
isocitrate dehydrogenase phosphorylation cycle; William 
B. Orr, M.D., Ph.D., Psychiatry, $5,000, Study of lexi-
cal processing in the elderly and in patients with early 
Alzheimer's disease using positron emission tomography; 
Robert Patterson, Ph.D., Physical Medicine and 
Rehabilitation, $6,640, Characterization of normal and 
burned tissue using impedance spectroscopy; Timothy W. 
Schacker, M.D., Medicine, $10,000, Design and imple-
mentation of a comprehensive system of data manage-
ment for HIV clinical research; and Elsa G. Shapiro, 
Ph.D., Neurology, $7,000, Does lead overburden affect 
salivary cortisol levels and disposition to aggressive 
behavior? 
FALL SPECIAL GRANTS include: Craig A. 
Henke, M.D., Medicine, $8,777, Induction of fibroblast 
apoptosis by Anti-CD44 antibody; Nancy Raymond, 
M.D., Psychiatry, $10,000, Equipment for testing cardiac 
vagal tone in eating disorder subjects for study "Food 
intake, satiety and pain in obese binge eaters"; S. 
Hossein Fatemi, M.D., Ph.D., Psychiatry, Cell Biology 
and Neuroanatomy, $20,000, The role of polysialilated 
NCAM in migration and differentiation of mouse neu-
ronal cells following prenatal exposure to influenza; and 
David Thomas, Ph.D., Biochemistry, $15 ,000, Cell cul-
ture for cardiac membrane biophysics. 
STUDENT GRANTS include: David Larson, 
"Inhibition of complement and its effect on 
xenotransplantation," conducted under the supervision 
of R. Morton Bolman III, M.D.; Patrick Townley, 
"Which products of the cytomegalovirus and what cell 
mechanisms are responsible for the endothelial cell accu-
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mulation of cytoplasmic p53," conducted under the 
supervision of Gregory M. Vercellotti, M.D.; Bryan 
Wood, "Characterization of the effect of hyperthyroidism 
on extraocular muscle apoptosis and growth factor 
expression," conducted under the supervision of Unda 
McLoon, Ph.D.; and Laurie Wright, "Hormonal 
regulation of sodium pump activity in lung epithelial 
cells," conducted under the supervision of David Ingbar, 
M.D . • 
AFFILIATE 
ORGANIZATIONS 
Children's Cancer 
Research Fund 
The 16th annual Dawn of a 
Dream benefit on January 18 includ-
ed the opportunity to bid on two of 
the most unique items ever present-
ed to CCRF - life-size replicas of 
the magnificent Terra Cotta 
Warriors in China, and a brilliant African gray parrot. 
CCRF founders Norm and Diana Hageboeck were 
recently recognized by Mpls . St. Paul Magazine in its 
eighth annual Twin Citian Volunteer Hall of Fame. 
Lee Kopp, president of Kopp Investment Advisors, 
led CCRF's first planned giving seminar. Held Tuesday, 
November 12, at Interlachen Country Club, the seminar 
attracted nearly 40 individuals interested in preserving 
their estates and supporting the fight against childhood 
cancer. This is the first of many topical subjects the 
Planned Giving Committee plans to provide to friends of 
CCRE 
Board member Patricia McHugh completed a photo 
display project for CCRF entitled "Childhood Cancer: 
Facing the Facts." The collection of photos represents a 
joint effort of physicians, nurses, parents, patients, a pho-
tographer, and several other volunteers. Children, ages 
two months to 20 years, who have been treated at the 
University of Minnesota Hospital and Clinic are featured 
in this collection. The children were photographed by 
Steve Schneider. The exhibit was displayed at the 
CCRF Showhouse at the Mall of America and will be 
featured at future CCRF events and activities. 
The Junior Benefactors Circle, also known as the 
Caterpillar C lub, has been established at CCRE The 
Circle includes individuals and couples in their 20s and 
30s who have donated $250 or more to CCRF this year. 
The Junior Benefactors Circle mission is to draw a new 
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generation of volunteers into the ranks of the organiza-
tion. The goal is to raise money for specific CCRF needs 
while socializing and having fun. Two events per year 
are planned, one in the fall and one in late spring/early 
summer. The Caterpillar Club celebrated on November 
2 with a bonfire and casual chili dinner. 
CCRF and Country Home magazine brought a fu lly 
decorated showhouse to the public at the Mall of 
America. Visitors toured the home through December 
31. Ron Schuth won the home and its furnishings- a 
retail value of $400,000, on January 1. Over $225,000 
was raised for CCRF from the log home prize drawing 
donations last year and more than 40,000 people entered 
the drawing. For more information, call612-893-9355 
or 1-800-922-1MME • 
Diabetes Institute for 
Immunology and Transplantation 
A world expert in islet r. 
trans lantation, Dr. Dl A B ETES INSTITUTE p FOR IWt.IU NOLOGY .&.IIDT RUSPLANTATION 
Bernhard J. Hering, from 
Giessen, Germany, has 
joined the Diabetes Institute. As leader of the islet pro-
gram, he brings exceptional expertise in islet research 
and transplantation to the University of Minnesota. 
Of the last 12 consecutive islet transplants per-
formed by Hering's group at Justus Liebig University, 11 
patients have maintained islet graft function for more 
than six months associated with marked improvement of 
glycemic control and absence of severe hypoglycemia. 
Four patients have already discontinued insulin injec-
tions completely. 
Under his direction, the Institute hopes to develop 
islet transplantation as the treatment of choice for the 
majority of patients afflicted with Type I diabetes melli-
tus, while continuing to offer pancreas transplants-
currently the only therapy that achieves insulin-indepen-
dence. In early 1997, Hering will begin expanding efforts 
in islet transplantation by starting comprehensive clini-
cal trials. 
The Diabetes Institute is very thankful to the fol-
lowing individuals and foundations who recently became 
Institute Founder's Circle members by giving $10,000 or 
more in support of the Institute's mission: Toby and 
Penny Cohn, Calla and James Fullmer, Dr. Bernhard J. 
Hering and Nicole Kirchhof, Michael Hoffman, Bill and 
Toni Meierhoff, Miller-Dwan Foundation of Duluth, 
Alice M. O'Brien Foundation, and St. Luke's Foundation 
of Duluth. For more information, call61 2-626-2101 or 1-
800-922-1MME • 
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International Hearing 
Foundation "•' li .. ''" ('av.o 
T .!' he International Hearing .SI---+-"-~-,;.;.--+~ 
Foundation (IHF) and its board 
continue to support missions and 
programs in research, education, 
and public service. Recently, Dr. Oleg Froymovich and 
Dr. Michael Shternfeld visited Dr. Malik Diop in 
Senegal, Africa, to provide gratis surgical care to indigent 
surgical patients, and to teach educational courses to 
physicians and other professional workers. 
Dr. Vikram Jaisinghani, an IHF fellow from India, 
recently arrived to study and conduct research in the 
Otopathology Laboratory and to observe otological clini-
cal care. Drs. Kawano and Sone, IHF fellows, are partici-
pating in research relating to molecular biology and otitis 
media and archival studies of human temporal bones. 
Support groups for Meniere's disease and tinnitus 
continue. For more information, call612-339-2120. • 
University of Minnesota 
Cancer Center T T 
T he University of Minnesota Cancer CAN 
Center's second annual Community 
Open House will be held April 6 at the \.....) 
Masonic Cancer Research Building, 
425 E. River Road, University of Minnesota. Visitors can 
tour the four-story Masonic Cancer Research Building 
and meet cancer researchers. For more information, call 
Lynn Roark, 612-626-5437 or visit the U ofM Cancer 
Center website: www.cancer.umn.edu. 
The Cancer Center recently recruited two faculty 
members: Julio Garcia-Aguilar, M.D., Ph.D., a colon and 
rectal surgeon, and David Largaespada, Ph.D., an assis-
tant professor of laboratory medicine and pathology with 
expertise in animal modeling. 
Bobbie Griffin, executive vice president, Medtronic, 
and president, Medtronic Pacing Business, was elected as 
the new UCAN Fund Board chair. For more informa-
tion, call612-626-1107 or 1-800-922-1MME • 
University Children's 
Foundation 
T he University Children's Foundation is proud to 
announce three new board members: Terri Cole, Targeted 
Media; David Gigerich, Workstations International; and 
Daniel J. Starks, Daig Corporation. 
The second annual Wine-Fest and Auction will be 
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held May 14-16. Raynelle 
Perkins, Jim Zechmann, and 
Steve Gill will co-chair this year's 
event. Haskell's Liquor and the 
Bacchus Society continue as 
major patrons. The three days of 
events include: Wine Maker 
Dinners at several Twin Cities restaurants on May 14, a 
Wine Tasting Evening on May 15, and a Fine Wine 
Dinner on May 16 sponsored by the Bacchus Society, 
Haskell's, and 40 other vintners. 
Money raised by the UCF WineFest and Auction 
funds the UCF Scholar Award annual grants awarded to 
outstanding scientists in the Department of Pediatrics 
whose research is vital to improving children's health. 
The second annual UCF/Dove Golf Tournament 
will be held in June. The Dove family (Ttm, Judy, and 
their daughter Angie Svien-Dove, a former patient of the 
Department of Pediatrics) ofNew Richmond, Wisconsin, 
and Action Battery Wholesalers, Inc., will host a golf 
tournament and pig roast at Bristol Ridge Golf Course in 
Somerset. 
For more information, call 612-625-14 71 or 1-800-
922-1MME • 
Vision Foundation 
T he first annual Visions from the 
Past/Hope for the Future event will 
be held April 26 at the James J. 
Hill Mansion in St. Paul. The 
theme is "An Evening of Victorian 
MINNESOTA 
EYE 
C!i§i·ft1iiiij.tliiii*H 
Romance" and activities will include recognition of new 
giving club members, house tours, concerts, dinner, and 
more. Funds raised will support the Department of 
Ophthalmology's research and education programs. 
The Vision Foundation has appointed nine new 
board members: Oscar Anderson, M.D.; Larry Johnston; 
Norm McCarthy; Stephen Otto; Rene Pelletier, M.D.; 
Charles Roach, M.D.; Jack St. Martin; Marilyn Swenson; 
and Thomas Woessner. James Bradshaw was appointed 
president, David Bolt is vice president, and Betty Jane 
Walen was appointed secretary. 
The next series of Gift of Sight Tours will be con-
ducted in May. Friends of the Vision Foundation are 
invited to visit the Department of Ophthalmology's 
research laboratories and education facilities. Stops 
include the Lions Children's Eye C linic and Lions 
Research Building. 
For more information call61 2-625-9613 or 1-800-
922-1MME • 
SPRING 1997 
ALUMNI NEWS & NOTES 
Medical Alumni Society 
President's Report 
I want to tell you about some exciting changes in our alumni programming. Several new things are being planned that will provide more opportuni-ties for everyone. We will be changing our 
reunion program from one weekend to two separate 
events and inviting more alumni to participate. In addi-
tion, we will be holding our Spring Alumni Social again. 
Spring Alumni Weekend, June 5-7, will feature 
reunions for the classes of 1947, 1952, 1957, 1962, 1967, 
and 1972. The Half Century Club (those graduates who 
have already celebrated their 50th reunion) will also 
gather on this weekend. The weekend includes the 
Reunion Dinner, a Deans' Reception and Dinner, special 
tours, an alumni golf outing at the University Golf 
Course, a Continuing Medical Education course, and 
most importantly, an opportunity to visit with old friends 
and colleagues. 
At the first Fall Alumni Weekend, September 26-
27, we will welcome the classes of 1977, 1982, 1987, and 
1992 back to the University for their reunions. Events 
include a Reunion Dinner, special tours, golf, Gopher 
football, tailgating, and more. A special function for 
Duluth graduates will also be included. If you would like 
to be involved in organizing your class reunion, please 
contact the alumni office. 
Our Spring Alumni Social is being planned - details 
will soon be sent toT win Cities area alumni. We hope to 
provide an opportunity to talk with the new dean of the 
Medical School and visit some new campus facilities. 
The Medical Alumni Annual Fund results are ahead 
of last year's, but your support is still needed. You may 
designate your gift to any area you wish or to unrestricted 
funds, which support student scholarships and research 
programs. 
Thank you to all those who signed up to be mentors. 
We matched more than 50 alums with first-year medical 
students and we have received great feedback. We 
always need alums who would like to donate their time, 
either through service on the Alumni Board, working 
with students, or committee service. Contact the 
Alumni Office at the Minnesota Medical Foundation 
612-625-1440 or 1-800-922-1663. 
Wayne D. Liebhard, M.D. , '83 
President, Medical Alumni Society 
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Spring Alumni 
Reunion Weekend 
June 5-7, 1997 
Minneapolis, Minnesota 
Classes of 1972, 1967, 1962, 1957, 1952, 1947, 
and Half Century C lub 
Thursday Evening 
Welcome Reception 
Friday 
Half Century Club Program and Luncheon 
Tours 
Medical School Graduation 
Deans' Reception and Dinner 
or Individual Class Functions 
Saturday 
Reunion Golf Outing 
New Horizons In Minnesota Medicine (CME) 
Tour 
Estate Planning for Physicians and Friends 
Reception & Meclical School Class Reunion 
Dinner & Programs 
All alumni are welcome to participate in 
Reunion Weekend Events. 
Call 612-625-8676 or 1-800-922-1663 for more 
information on Alumni Reunion Weekend. 
Fall Alumni 
Reunion Weekend 
September 26-27, 1997 
Minneapolis, Minnesota 
C lasses of 1992, 1987, 1982, and 1977 
Friday Evening 
Reception & Dinner Dance 
Saturday 
Golf 
Financial Planning for Younger Physicians 
Tailgate/Football Game 
All alumni are welcome to participate in 
Reunion Weekend Events. 
Call 612-625-8676 or 1-800-922-1663 for more 
information on Alumni Reunion Weekend. 
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CLASS NOTES 
1947 
Dr. John E. Verby, Jr. , 
Bloomington, Minnesota, 
serves as a consultant to 
both the Osteopathic 
School of Medicine in 
Long Island, New York, 
and the General Practice 
Physicians in Leuven, 
Belgium. He recently 
received the Carleton 
College Achievement 
Award in honor of his work. 
1960 
Dr. L. Ashley Whitesell, 
G lendale, Arizona, recent-
ly relocated to Arizona to 
practice occupational 
medicine. 
1962 
Dr. Richard R eem, 
Fairbanks, A laska, retired 
after eight years of active 
U.S. Army status and 20 
years in the Army 
National Guard. 
1964 
Dr. AI Shemesh, Capis-
trano Beach, California, 
recently appeared as a 
guest on the "Oprah 
W infry Show" to discuss 
the future of new treat-
ments for obesity. 
1966 
Dr. Stephen L. Hanson, 
Benson, Minnesota, relo-
cated in January from 
Glenwood, Minnesota, to 
practice at the Benson 
Medical Center. He will 
be working with Dr. 
R ichard Horecka, '80. 
A captain in the Naval 
Reserve Medical Corps, 
Hanson recently complet-
ed two weeks of active 
duty at the Naval Hospital 
in Pensacola, Florida. 
1970 
Dr. Harold R. Veits, 
Lubbock, Texas, has 
recently relocated from a 
private psychiatry practice 
in Bangor, Maine, to 
become an academic psy-
ch iatrist at the Medical 
SchoolofTexasTech 
University in Lubbock. 
1977 
Dr. Joanne B. Rogin , 
Minnetonka, Minnesota, 
has been elected president 
of the Minnesota 
Society of Neurological 
Sciences. She was also 
elected a fellow of the 
American Academy of 
Neurology. Rogin prac-
tices adult neurology at 
the Minneapolis C linic of 
Neurology and is medical 
director of the Midwest 
Center for Seizure 
Disorders. 
1978 
Dr. Fred L. Rasp, Fort 
Wayne, Indiana, was 
appointed medical direc-
tor of the Medical Group 
of Fort Wayne. Rasp has 
practiced in Indiana since 
1985. 
1980 
Dr. Penny Langland, 
Thief River Falls, Minne-
sota, was selected to 
receive Planned 
Parenthood's Physician of 
the Year Award in 
November of 1996. In 
addition to working at the 
Planned Parenthood din-
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ic in Thief River Falls, 
Langland also practices at 
the Dakota C linic. 
1981 
Dr. Bruce A. Orkin, 
Washington, D.C., was 
promoted to associate pro-
fessor of surgery with 
tenure and was appointed 
director of the Division of 
Colon and Rectal Surgery 
at the George Washington 
University, Washington, 
D.C. 
1987 
Dr. Thomas J. Vererka, 
Saginaw, Michigan, estab-
lished a solo private prac-
tice in general surgery and 
surgical critical care. He 
currently serves as an 
associate clinical professor 
and preceptor at Michigan 
State University, where 
he teaches general surgery 
residents. 
1990 
Dr. Patrick M. O'Reilly, 
Maplewood, Minnesota, 
finished his gastroenterol-
ogy fellowship at UCLA. 
O'Reilly will relocate to 
St. Paul to practice with a 
group of gastroenterolo-
gists. 
1991 
Dr. David Pollak, St. 
Louis Park, Minnesota, 
completed his psychiatry 
residency at the University 
of Colorado in 1995. After 
relocating to Minnesota, 
he practiced at Abbott-
Northwestern Hospital 
and provided consultation 
services to area agencies. 
He is now opening a 
private practice in psycho-
therapy and psychiatry in 
Minneapolis. 
1993 
Dr. Jennifer S. Smith, 
Bristol, Maine, recently 
completed her residency 
at Maine Medical Center. 
She now practices with 
the Miles Medical Group 
in Damariscotta, Maine. 
IN MEMORIAM 
CLARENCE E. ARLANDER, M.D., C lass of 1929, 
Falcon Heights, Minnesota, died January 12 at age 91. 
He served as a medical officer in the U.S. Navy during 
World War II, and as a physician in Northeast Minnea-
polis for 40 years. He is survived by his son, Dr. Thomas 
Arlander. 
GENEVIEVE A. ARNESON, M.D., C lass of 1953, 
Pass Christian, Mississippi, died November 16 at age 74. 
She became a Life Fellow of the American Psychiatric 
Association in 1989. After completing her residency in 
psychiatry at the Louisiana State University School of 
Medicine in 1958, Arneson remained at LSU for over 30 
years. Arneson assisted in the development of the West 
Jefferson Mental Health Center in Louisiana and was its 
medical director from 1964 to 1990. 
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7th Annual 
Golf Classic 
Monday, August 25, 1997 
Rolling Green Country Club 
Hamel, Minnesota 
Double Shotgun Start 
(morning and afternoon starts) 
Scramble Format 
Entry Fee $200 ($60 tax-deductible) 
T he Minnesota Medical Foundation Golf Classic, now in its seventh year, has be-come one of the Twin Cities' premier golf 
events. The scramble format tournament provides a 
challenging but enjoyable round of golf for players 
of all skill levels. 
Last year's event raised more than $70,000 formed-
ical research and scholarships at the University of 
Minnesota Medical Schools (Minneapolis and 
Duluth). The past five tournaments have raised a 
total of $190,000. 
Golfers may sign up as a foursome or as individuals. 
Interested parties are encouraged to call for more 
information soon. Space is limited and the past few 
Classics have all been sellouts. For more information 
or to register call 612-625-1440 or 1-800-922-1663. 
HELEN B. BARTON, M.D., C lass of 1933, Golden 
Valley, Minnesota, died October 3 at age 87. Barton, 
author of Nervous Tension Behavior & Body Function, was 
active with the American Association of University 
Women, Minneapolis. She received the American 
Psychiatric Association 50 Year Service Award. Barton 
also served as the clinical services director and assistant 
superintendent at the Mental Health Institute in 
Independence, Iowa. She is survived by three children. 
MAURICE W. BEERS, M.D., Class of 1972, Fergus 
Falls, Minnesota, died in December 1994. He specialized 
in family practice. 
GEORGE J. BOODY, JR., M.D., C lass of 1933, St. 
Paul, Minnesota, died September 15 at age 88. He 
worked at a private practice in Dawson, Minnesota, until 
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1953. He then entered the Minnesota State Hospital 
System, practicing first at Sandstone State Hospital and 
then at Cambridge State Hospital, where he served as 
acting medical director. He retired in 1976. Boody is sur-
vived by his wife, Esther, and two sons. 
ENOCH B. BRICK, M.D., Class of 1930, Wausau, 
Wisconsin, died August 19 at age 91. Brick practiced in 
Wausau as an ear-nose-throat specialist from 1938 until 
his retirement in 1971. He served as a commander in 
the Navy Medical Corps. Brick was on the staff at St. 
Mary's and Memorial Hospitals in Wausau, and on the 
faculty of St. Mary's Hospital School of Nursing. He is 
survived by two daughters. 
COLEMAN J. CONNOLLY, M.D., Class of 1942, St. 
Paul, Minnesota, died December 4. Connolly was a fel-
low in the American College of Surgeons, and was board 
certified in thoracic surgery in 1955. He was a clinical 
associate professor of surgery at the University of 
Minnesota Medical School, and served on the board of 
admissions. Connolly is survived by his wife, Peggy, and 
four children. 
ROBERT J. CUMMING, M.D., Class of 1961, St. 
Cloud, Minnesota, died November 9 at age 65. He is sur-
vived by his wife, Patricia, and 10 children. 
W. JOHN DAWSON, JR., M.D., Class of 1957, 
Wayzata, Minnesota, died in early December at age 75. 
He is survived by his wife, Margaret. 
JESSE E. DOUGLASS, JR., M.D., C lass of 1951, 
Tyler, Texas, died September 14 at age 78. Before com-
pleting his medical degree, Douglass served as pharma-
cist's mate in the U.S. Navy during World War II . After 
graduating, he practiced at a sanatorium near Walker, 
Minnesota. He then served as the medical director at 
Mineral Springs Sanatorium in Cannon Falls, Minne-
sota. Douglass is survived by four sons and a daughter. 
JOHN D. FREMSTAD, M.D., C lass of 1973, Wood-
bury, Minnesota, died in October at age 48. Fremstad, a 
prominent surgeon in St. Paul, was a partner of Minnesota 
Surgical Associates P.A. He is survived by four children. 
FLOYD K. GARETZ, M.D., C lass of 1955, St. Louis 
Park, Minnesota, died November 14 at age 72. He is sur-
vived by his wife, Diane, and five children. 
JOHN T. HACHIYA, M.D., Class of 1985, Edina, 
Minnesota, died November 28 at age 41. He was a physi-
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cian at Park Nicollet Medical Center since 1984, and a 
clinical associate professor in obstetrics and gynecology at 
the University of Minnesota. Hachiya was elected chair-
man of the Obstetrics and Gynecology Department at 
Park Nicollet Medical Center in 1989. Hachiya served 
on the board of the Women's Health Fund, and was pres-
ident of the Obstetrics and Gynecology Alumni and 
Friends organization. He is survived by his wife, Mary 
Beth, and four children. 
LYLE J. HAY, M.D., Class of 1937, Buffalo, Minnesota, 
died January 9 at age 83. He was charter president of the 
Minnesota Chapter of the American College of Surgeons. 
He served in the 26th General Hospital Unit in the Army 
during World War II. He became a professor of surgery at 
the University of Minnesota Medical School in 194 7. 
From 1947 to 1952, Hay served as chief of surgery at the 
Minneapolis Veterans Medical Center. He was director 
of surgical research and medical education at Mount Sinai 
Hospital in Minneapolis from 1952 to 1959. Until his 
retirement in 1981, he was director of the intern-resident 
training program at the St. Barnabas and Swedish hospi-
tals in Minneapolis, and chief of surgery and president of the 
medical staff at Metropolitan Medical Center, also in Minne-
apolis; He is survived by two sons and three daughters. 
CARL B. HEGGESTAD, M.D., Class of 1957, Fridley, 
Minnesota, died May 26 at age 65. Heggestad specialized 
in anatomy. He is survived by his wife, Gloria, one 
daughter and two sons. 
CURT W. LUNDQUIST, M.D., Class of 1934, Blue 
Earth, Minnesota, died December 31 at age 89. He 
served in World War II in the Army Medical Corps. 
Lundquist practiced ophthalmology in Owatonna until 
his retirement. He is survived by a daughter and son. 
SHELDON C. MANDEL, M.D., Class of 1945, Los 
Angeles, California, died August 22. Mandel specialized 
in internal medicine. He is survived by his wife, Renee. 
EVELYN W. MAYMAN, M.D., Class of 1927, 
Modesto, California, died January 18, 1995, at age 93. 
She completed her internship in San Francisco, and 
became the second female doctor in Stanislaus County, 
California. She is credited with establishing the county's 
first blood bank, establishing a dairy fann to produce pas-
teurized milk in response to the tuberculosis plague, and 
co-founding the Gould Medical Group in Modesto. 
ROBERT 0. McMAHAN, M.D., C lass of 1953, 
Eugene, Oregon, died June 7 at age 67. He worked as a 
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radiologist at Sacred Heart Medical Center in Oregon 
until his retirement in 1990. He was past president of the 
Oregon Radiological Society and past second vice presi-
dent of the Pacific Northwest Radiological Society. He is 
survived by his wife, Carol, and nine children. 
NICHOLAS J. MUSTY, M.D., C lass of 1940, White-
fish Lake, Minnesota, died November 17 at age 89. A 
Major in the U.S. A ir Force, Musty served as a flight sur-
geon during World War II. He was head football coach 
and athletic director at the College of St. Thomas in St. 
Paul in the late 1930s, and was inducted into the St. 
Thomas Athletic Hall of Fame. He practiced obstetrics 
and gynecology in Minneapolis until he retired in 1972. 
He is survived by two sons. 
JAMES J. O'LEARY, M.D., C lass of 1973, St. Paul, 
Minnesota, died September 19 at age 49. O'Leary spe-
cialized in pathology. He is survived by his wife, Denise, 
and five daughters. 
KENNETH H. PETERSON, M.D., C lass of 1944, 
Hutchinson, Minnesota, died July 28 at age 77. He spe-
cialized in family practice. He is survived by his wife, 
Hulda, two sons and one daughter. 
ANDREW REARDON, M.D., C lass of 1954, Duluth, 
Minnesota, died April 14 at age 68. Reardon practiced at 
the Duluth C linic from 1957 to 1990 as a pediatrician. 
He was an associate professor at the UMD School of 
Medicine for 16 years. He is survived by his wife, 
Catherine, one son and two daughters. 
JEROME J. SCHEREK, M.D., C lass of 1957, Annan-
dale, Minnesota, died January 5 at age 64. He established 
an OB/GYN practice in St. Paul, where he remained for 
25 years. Scherek was an associate clinical professor in 
OB/GYN at the University of Minnesota Medical 
School, and served as chief of staff at St. Joseph's Hosp-
ital. He was the president of the Minnesota Obstetrical 
& Gynecologic Society and chairman of the Prenatal 
Guidelines Task Force in Minnesota. He is survived by 
his wife, Barbara, and four daughters. 
JOHN E SCHMID, M.D., C lass of 1941, Hilton Head 
Plantation, South Carolina, died August 5 at age 79. He 
served in the Army Medical Corps as a major during 
World War II, where he was awarded the Army Com-
mendation Medal for his work with tropical diseases. He 
then returned to the University of Minnesota Graduate 
School to study dermatology. In 1949 he entered private 
practice at a clinic in Duluth. In 1983 he joined the staff 
SPRING 1997 
of the Hilton Head Hospital in South Carolina. He re-
mained there until his retirement in 1990. He is survived 
by three daughters and a son. 
RAYMOND A. SCHWEGLER, M.D., Ph.D., C lass of 
1930, Lawrence, Kansas, died in July. He is survived by 
his wife, Alice. 
HARRY N. SIMMONDS, M.D., C lass of 1943, St. 
Paul, Minnesota, died in early November at age 77. 
Simmonds established a permanent practice in St. Paul 
in 1965, after serving as chief of staff at St. Francis 
Hospital. He was a veteran of the Korean War, and 
received a Bronze Star. He was elected a Fellow of the 
Royal Society of Health in London in 1971. 
LINDSEY K. SORENSON, M.D., C lass of 1992, St. 
Paul, Minnesota, died October 16 at age 32. He is sur-
vived by his wife, Christa, and three children. 
HAROLD C. STRATTE, M.D., C lass of 1920, 
Windom, Minnesota, died April1 5 at age 102. Stratte 
began his medical career by helping his father fill and 
deliver prescriptions in a horse and buggy. After graduat-
ing from medical school, he served in the Army during 
World War I. He practiced medicine in northern and 
southwestern Minnesota for 65 years, seeing his last 
patient when he was 92. Stratte is survived by two 
daughters and a son. 
ROBERT W. UTENDORFER, M.D., C lass of 1947, 
Edina, Minnesota, died in October at age 84. Utendorfer 
was a clinical professor emeritus of surgery at the 
University of Minnesota Medical School. He served in 
the Army during World War II. He practiced at the 
Minneapolis Veterans Medical Center for eight years and 
then started his own practice in Minneapolis. Utendorfer 
is survived by a son and a daughter. 
FREDERICK H. VAN BERGEN, M.D., Class of 
1941 , Minneapolis, Minnesota, died September 11 at age 
82. Van Bergen was head of the Department of 
Anesthesiology at the University of Minnesota Medical 
School for 23 years. It is estimated that he trained 350 
anesthesiologists prior to his retirement in 1978. He 
completed his residency in anesthesiology after serving i 
n the Navy in the South Pacific during World War II . 
Van Bergen worked with the Elmer Smith Co. to 
develop the Van Bergen respirator, a device used to help 
polio patients. He is survived by his wife, Nancy, and 
four sons. • 
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Dear Gary, 
Gary G. Hargraves 
Can real estate be used to 1) take advantage of the 
$10,000 annual exclusion gifting; 2 ) reduce estate taxes, 
3) gift to children, and 4) make charitable gifts? 
Yes, if a person is charitable, patient, persistent, has an interest in lowering taxes, and is will-
ing to make modest cash gifts to achieve substantial tax savings. 
Tax law and the IRS provide for many tax savings, but make us plan to take advantage of 
them. This is where the staff of the Minnesota Medical Foundation can help. We can do much 
of the work to keep the process relatively simple. 
For example: Neal Gault, Jr. , M.D., C lass of 1950, Dean Emeritus of the Medical School, 
has real estate valued at $180,000 with a cost basis of $12,600. At one time, this property had 
considerable personal value, but now it is unused, unwanted, and unneeded by both Dr. Gault 
and his ch ildren and requires management and money. 
If Dr. Gault gifts the real estate to his children either during or after his life, there is a 
gift/estate tax liability of approximately $90,000. If Dr. Gault sells the real estate, there is an 
immediate capital gains tax liability of $47,000 plus a gift tax of 50 percent on any remain ing 
portion that may pass to children later. Dr. Gault has three children and is not currently fully 
using the $10,000 annual gift exclusion tax savings opportunity, $30,000 for three ch ildren. 
Dr. Gault decides to gift an undivided interest in the real estate of approximately $30,000 
per year for several years into a charitable trust. All of the above tax liabilities are bypassed and 
the trust provides a 5 percent income to the children for their lives and then a generous gift to 
the Minnesota Medical Foundation. In addition, Dr. Gault receives a modest current year 
charitable deduction. 
If you have real estate (or other assets) and you are looking for options available to you, 
we would welcome the opportunity to discuss how we may be of assistance in helping you 
accomplish multiple objectives. Please call Gary Hargraves at: 612-625-5463 or 800-922-1663 
or return the reply below. 
___ Please call me to discuss how I may use real estate (or other assets) to save taxes and 
achieve multiple objectives. 
My phone# is: ____________ _ Best time to call me is: ________ __ _ 
Name _______________ _____________________ _ 
Address: ______________ ____________ _________ _ 
C ity/State/Zip. _____ ____ _____________ ________ _ 
Please return to: Gary G. Hargraves, Minnesota Medical Foundation, Box 193 UMHC, 
420 Delaware St. SE, Minneapolis, MN . 55455-0392 MB-897 
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THANKS FOR GIVING 
Dr. Fred BoUum 
by Jean Murray 
f the train from Pepin, Wisconsin, had gone 
directly to Madison, Fred Bollum's life might 
have taken a different turn. As it was, the 
16-year-old headed to Minneapolis, eager to 
begin his education at the University of Minnesota. 
"] began the University on my seventeenth 
birthday," says Bollum. 
A zoology major, he attended a seminar his senior 
year taught by Professors Cyrus P. Barnum, Wallace D. 
Armstrong, F. O tto Schmidt, and H. Burr Steinbach. It 
was only 1950, but the topic under discussion was the 
replication of DNA The young student knew he had 
found his field . 
Bollum went on to get his Ph.D. in physiological 
chemistry, and his advisor was C.P. Barnum. "I learned 
just about everything I know in my field from him," says 
Bollum. "Cy's teaching and research prepared many of us 
with opportunities for success in our futures." 
Along the way Bollum served in the U.S. Coast 
G uard late in World War II and in the Navy during the 
Korean War. He held a U.S. Public Health Service 
Postdoctoral Fellowship at the University of Wisconsin, 
was a biochemist at the Oak Ridge National Laboratory 
(ORNL) in Oak Ridge, Tennessee, professor of biochem-
istry at the University of Kentucky Medical School, and 
chair and professor of biochemistry at the Uniformed 
Services University of the Health Sciences in Bethesda, 
Maryland. 
At the University of Wisconsin Bollum discovered 
the major DNA replication enzyme in mammalian tis-
sues and later, at O RNL, a second DNA polymerase 
thought to be involved in generation of immunological 
diversity. 
His interest in DNA lasted not only for his scientific 
career but on into retirement. Bollum now heads a small 
biotechnology company that is involved in the produc-
tion of enzymes, antibodies, and polynucleotides. These 
are products developed during Bollum's earlier career 
which are used in genetic engineering and medical diag-
nostics. 
Bollum has generously supported both the Wallace 
S PRlNG 1997 
Dr. Fred Bollum with Anne Barnum, widow of 
Cyrus P. Barnum. 
D. Armstrong Memorial Award and the Cyrus P. Barnum 
Teaching Fellowship, and has recently established the 
Frederick James Bollum, Ph.D., Endowed Research Fund 
through the Minnesota Medical Foundation to enrich 
research activity in the Department of Biochemistry at 
the University of Minnesota. 
The Frederick James Bollum, Ph.D., Endowed 
Research Fund will support small research projects or 
other research activities such as minisymposia, work-
shops, postdoctoral and graduate student stipends, and 
matching funds for essential shared research equipment. 
Fred Bollum feels it is critically important - and a 
"most pleasurable experience" - to give back to the 
insti tution that educated him and provided the founda-
tion for his lifetime career. "If it weren't for the 
University of Minnesota, I could be working on the rail-
road!" 
The Minnesota Medical Foundation and the 
Department of Biochemistry are very grateful to Fred 
Bollum for his generosity. • 
MINNESOTA 
MEDICAL Box 193 
420 Delaware Street SE 
fOUNDATION Minneapolis, MN 55455-0392 
at the University of Minnesota 
ADDRESS CORRECTION REQUESTED 
Otht'l I"'"' I !•mail \J\H ll.m.ul \\<hm,,,t<r 
Visit our ~ebsite 
We are pleased to announce that the 
Minnesota Medical Foundation's website 
is up and running. Please visit us at 
http://www.med.umn.edu/ mmf 
We look forward to receiving your comments. 
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